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ABSTRACT
EXERCISE PRECONDITIONING AND TFAM OVEREXPRESSION DIMINISH
SKELETAL MUSCLE ATROPHY
Nicholas T. Theilen
March 23, 2018
This dissertation is an analysis of skeletal muscle atrophy and a molecular
assessment of potential preventative treatments. Chapter I begins with a background of
skeletal muscle atrophy along with an analysis of associated molecular pathways. Here,
we discuss how skeletal muscle atrophy is the consequence of protein degradation
exceeding protein synthesis and can occur when a muscle is abnormally disused. The
development of therapies prior to skeletal muscle atrophy settings to diminish protein
degradation is scarce and could be useful to prevent negative clinical outcomes of
patients who must unload and disuse musculature over extended periods. Mitochondrial
dysfunction is associated with skeletal muscle atrophy and contributes to the induction of
protein degradation and cell apoptosis through increased levels of ROS. This damages
mtDNA, leading to its degradation and mutation resulting in dysfunctional mitochondria.
Mitochondrial transcription factor A (TFAM) protects mtDNA from ROS and
degradation while increasing mitochondrial function and the transcription of
mitochondrial proteins. Exercise stimulates mitochondrial function by activating cell
signaling pathways that converge on and increase PGC-1α, a well-known activator of the
transcription of TFAM and mitochondrial biogenesis. Therefore, we first hypothesize
v

exercise training prior to muscle unloading and disuse will prevent skeletal muscle
atrophy. Additionally, we hypothesize this protective effect of exercise in preventing
skeletal muscle atrophy is associated with increased mitochondrial markers. In Chapter
II, we test these hypotheses by first inducing skeletal muscle atrophy using hindlimb
suspension (HLS) and exercising mice prior to this suspension. The results indicated
exercising prior to HLS reduced many of the morphological and molecular changes
within the muscle associated with atrophy. Also in Chapter II, we follow up these
findings through mitochondrial molecular analyses with results showing exercise
increasing mitochondrial-associated markers and redox balance. We also find decreases
in TFAM after HLS, which led to further analyses through the use of a TFAM
overexpression transgenic mouse model in HLS. We reason if HLS induces excessive
ROS accumulation and decreases TFAM, overexpressing this gene may prevent
mitochondrial dysfunction mechanisms associated with atrophy. Therefore, we
hypothesize the overexpression of TFAM diminishes skeletal muscle atrophy and,
secondarily, TFAM overexpression combined with exercise training will synergistically
prevent atrophy caused by HLS. To assess these hypotheses, in Chapter III we subject
TFAM mice to HLS as well as exercising TFAM mice prior to entering HLS. Results
here reveal TFAM overexpression diminishes skeletal muscle atrophy caused by HLS
and combining exercise and TFAM overexpression resulted in no significant difference
compared to exercising prior to HLS in wild-type mice. Collectively, the data indicate an
important role for exercise and TFAM in diminishing skeletal muscle atrophy.
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CHAPTER I
GENERAL INTRODUCTION

Skeletal Muscle Atrophy
Skeletal muscle serves many important functions affecting the human physiologic
state. Standard perception of the function of skeletal muscle is generally in propulsion for
locomotion and desired movement, such as the musculature of the upper legs contracting
and relaxing to extend and retract the lower leg at the knee joint repetitiously as part of
the coordination of walking. However, this tissue also serves as an important amino acid
and glucose reservoir and is the largest metabolically active organ in the human body
(117). Pathological loss of this tissue, known as skeletal muscle atrophy, is associated
with numerous health abnormalities and can greatly affect quality of life.
Skeletal muscle atrophy is caused by a host of factors including disease, ageing,
injury, nutritional decrements, and disuse. It is characterized by a decrease in the crosssectional area of the muscle, a decline in force generative capabilities, decreases in
functional proteins of the muscle mass, and a loss of oxidative ability making the tissue
less resistant to fatigue (140). The scope of the present dissertation project will focus on
the atrophic aspects of muscle disuse.
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The abnormal disuse of muscle occurs for many reasons including bed rest from
disease or injury, cast immobilization due to injury, spinal cord injury, weightlessness
environments, and a sedentary lifestyle. Ultimately, reduced muscle contraction and
mechanical stress from a lack of loading stimuli on the muscle encompasses disuse.
When this happens, increased activation of protein signaling pathways leading to protein
degradation and apoptosis arise with corresponding downregulation of protein synthesis
pathways (140). This imbalance is depicted in Figure 2.
Skeletal muscle atrophy can be gravely debilitating and is associated with
increased morbidity and mortality (113). One can imagine a scenario in which a patient is
prescribed bedrest for an extended time, due to injury, and accumulates significant
muscle atrophy which renders this person incapable of performing basic physical tasks,
such as simply rising out of bed. Diminished force production from atrophic muscles is
associated with the onset of fatigue and a potential, further reduction in physical ability.
Not only is the patient’s quality of life harshly diminished, healthcare costs in the form of
medications and rehabilitation sharply increase to attempt to combat this condition.
Therefore, it is important, both medically and fiscally, to study interventions that may
potentially prevent atrophy.
There is a clear link in the literature with skeletal muscle atrophy to the
dysfunction of the mitochondria (69, 96) and redox imbalance (114) to the induction of
degradation and apoptotic pathways, which results in the physical reduction of the tissue.
The study of these molecular mechanisms associated with atrophy is warranted to
increase our understanding of this condition and potentially create molecularly directed
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Figure 1. Molecular scale of atrophy. Scale representation of the molecular imbalance
of skeletal muscle atrophy. Degradation and apoptosis exceeding protein synthesis results
in atrophy over time.
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therapies of the future. To be able to do this, we must have a clear understanding of what
causes atrophy to lead to how we can prevent the condition.

Protein degradation. Disuse-induced muscle atrophy has many causes, as previously
stated. While the causes occur from different scenarios, they all similarly reduce
mechanical stress and fiber contraction in the muscle. The mechanical stress of
contracting skeletal muscle under a physical load in a healthy individual causes many
changes throughout skeletal myocytes. Contraction induced by myosin and actin crossbridging is sensed by the cell via proteins such as dystrophin and integrin complexes (5).
Dystrophin is a cytoplasmic protein that interacts, on one end, with actin fibers under the
cell surface and, on the opposite end, associates with membrane-bound proteins that form
a dystrophin complex spanning the entire sarcolemmal membrane (40). During actin and
myosin contraction, lateral force production is created in the myofilaments. Anchoring
proteins, such as dystrophin and the associated complex, turn this lateral force into linear
force to disperse across the sarcolemma. Through adhesion molecules, such as laminin,
this linear force is converted back into lateral force as it transmits through the
sarcolemma and into the extracellular matrix throughout the muscle. This acts as a “shock
absorber” and provides stiffness to the contracting myocyte and prevents the initial lateral
force of the myofilaments from being transferred into the sarcolemma inappropriately,
causing deformation of the membrane.
Pasternak’s group demonstrated this by using dystrophin knockout (mdx) mice
lacking this protein (similar to humans with Duchenne muscular dystrophy). Mdx mice
displayed fragile myotubes with roughly 4 times less stiffness than normal myotubes
5

(108). This important protein and its respective complex, along with other sensory
complexes (integrin), activates focal adhesion kinases (FAKs) and mediates the
prevention of apoptosis and activation of growth pathways (5). With unloading and
disuse, mechanical stress is greatly reduced and the corresponding growth signaling and
apoptosis prevention is prohibited. Further, lack of contraction leads to the activation of
catabolic pathways in skeletal muscle.
The ubiquitin-proteasome pathway is a main regulator of protein degradation.
Muscle ring finger-1 (Murf-1) and Atrogin-1/MAFbx are E3 ligases in skeletal muscle
that play a key role in ubiquitin marked degradation (45). These ligases are activated by
multiple stimuli, in particular ROS, inflammatory markers, and the unloading of muscle.
Activation of IκB kinase (IKK) occurs via these stimuli, which is associated with the
activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) (11).
NF-κB is a transcription factor responsible for transcription of many degradative genes.
In this case, NF-κB is able to translocate into the nucleus and play a role in the
transcription of Murf-1 and Atrogin-1/MAFbx. Mature Murf-1 and Atrogin-1/MAFbx
proteins polyubiquinate polypeptides in the muscle as a method of targeting the protein
for degradation. Skeletal muscles consist mostly of the myofibrillar proteins myosin and
actin involved in the functional aspect of the cells. Therefore, for significant atrophy to
occur, these proteins must be degraded.
Murf-1 is involved in targeting myosin light chains for degradation while atrogin1/MAFbx targets actin molecules (9). After these myofibrillar proteins are
polyubiquinated, proteasomes attach and degrade the protein resulting in atrophy. Tawa
et al. demonstrated the importance of the ubiquitin pathway by inhibiting proteasome
6

activity in the rat soleus muscle of three atrophy inducing pathological states
(denervation, hyperthyroidism, sepsis). Without altering protein synthesis expression,
protein balance increased with high percentages of reductions in proteolysis and an
increase in ubiquinated proteins of the muscle was observed (139). This study, among
others, delineated the ubiquitin-proteasome pathway as the key modulator of protein
degradation and thus, should be considered when working with skeletal muscle atrophy
models. It is possible that different pathways contribute to degradation in different
settings based upon the conditions of the model and should also be considered when
reviewing data.
Other protease contributors in skeletal muscle protein degradation include
calpains and lysosomes (16). Calpains are intracellular proteases that are regulated by
Ca2+. In skeletal muscle, calpain-1, calpain-2, and calpain-3 are mainly expressed.
Calpain-3 is downregulated during atrophy as well as in exercise suggesting that its
absence is necessary for atrophy (4). Recently, Shenkman and colleagues used an
inhibiting agent to diminish calpain-1 in a rat model while inducing skeletal muscle
atrophy by hindlimb suspension for 3 days. The soleus muscle size was significantly
reduced in rats that were only suspended while those suspended and treated with the
calpain-1 inhibitor retained muscle size (126). Calpain-1 levels were increased in the
suspension only model. Interestingly, levels of calpain-2 were not affected by hindlimb
suspension induced atrophy, indicating a key role of calpain-1 in short-term (3 days)
disuse. Inhibiting calpain-1 decreases MAFbx expression and inhibits protein
ubiquitination. Studies increasing the atrophy duration should be done to further elucidate
these changes in protein expression.

7

Lysosomal activity is also a contributing factor to protein degradation in muscle.
Autophagy using lysosomal machinery (autophagy-lysosomal system) is upregulated
during catabolic states of skeletal muscle (120). Normal contraction of muscle tissue over
time causes damage to the contracting proteins as well as organelles of the cell. For these
damaged proteins and organelles to be degraded and recycled to continue normal or
enhanced function, the cells must have a self-selecting degradative system. This system is
autophagy.
Again, NF-κB pathway is an important transcription factor inducing autophagy.
Autophagosomes consume defective proteins of the cell and transport the defective
material to lysosomes. Lysosomes are membrane-bound vesicles containing acid
hydrolases that, when released, degrade the cellular components of the autophagosome
(7). The process is also induced by multiple types of exercise (63, 124). This could be to
enhance the removal of damaged proteins due to the stress of exercise contractions or
may also be to provide energy for sustained contractions in the cell. While this process
positively impacts the function of skeletal muscle tissue, excessive autophagy-lysosomal
activity, as seen in many myopathies, leads to atrophy.

Cell apoptosis. Cells undergo a programmed cell death (apoptosis) due to specific
biochemical interactions that cause blebbing of the cell membrane, condensation of
chromatin, and cell fragment lysis resulting in the death of the cell. When skeletal muscle
is not contracting over time, as occurs in disuse, an increase in cell apoptosis has been
observed (130). As load and contractions of the muscle diminish, the removal of
myonuclei occurs and is associated with apoptosis (5) along with the destruction of
8

cellular proteins. The myonuclear domain is reduced, resulting in diminished function in
the myofiber.
Caspases are proteases within the cell that play a role in the disassembly of the
nucleus and cytoskeleton while cleaving many other cellular proteins. Caspases are
categorized as “initiators” and “executioners” with caspase-2, -6, -9, -10 being
characterized as initiators while caspase-3, -7, and -8 are executioners (20). Specifically,
caspase-3 is a major executioner involved in skeletal muscle atrophy. Signaling for
caspase-3 includes both extrinsic and intrinsic factors. Extrinsic factors include binding
of the tumor necrosis factor (TNF) ligand to TNF death receptors on transmembrane
proteins. This TNF binding causes a signal cascade that results in procaspase-8 and the
activation of the caspase-3 executioner. Capase-3 activates an endonuclease (CAD) that
degrades DNA (32) and thus, the execution of apoptosis.
A major intrinsic pathway leading to caspase-3 activation includes the release of
cytochrome c (Cyt c) from the mitochondria. Signals such as elevated levels of ROS and
reactive-nitrogen species (RNS) increase mitochondrial membrane permeability that
release Cyt c from the mitochondria (29). B-cell leukemia/lymphoma 2 (Bcl-2) and BclXL block the release of Cyt c and serve an anti-apoptotic role. Members of the Bcl-2
associated death promoter (BAD) family, such as BAX and BAK, serve as pro-apoptotic
factors and increase pore permeability of the mitochondria allowing the release of Cyt c
(160). Cyt c is then involved in the activation of the initiator caspase-9, forming an
apoptosome complex. This leads to the activation of the executioner caspase-3 and
degradation of cellular components (152). Leeuwenburgh et al. performed hindlimb
suspension on young and old rats over a 14-day period. Their results indicated an 84%
9

increase in caspase-3 activity in the soleus of young rats after inducing atrophy over 14
days (83). Furthermore, a study by Nagano and colleagues observed active caspase-3
activity in male Wistar rats after 3-weeks of hindlimb unloading (98). These studies
indicate an apoptotic link between disuse-induced muscular atrophy and caspase-3.
There are caspase-dependent and caspase-independent pathways that induce
apoptosis. Apoptosis-inducing factor (AIF) is released from the mitochondria upon
stimulation from pro-apoptotic signals. This AIF activates apoptosis through
chromosomal condensation and DNA fragmentation in a caspase-independent manner
(62). EndonucleaseG (EndoG) is a protein released from the mitochondria after proapoptotic signaling. EndoG is caspase-independent and is associated with DNA
fragmentation that coincides with apoptosis during muscle atrophy induced by hindlimb
suspension in aged mice (29). With a multitude of cell signaling pathways involved in
cell apoptosis, cross-talk is likely to occur between the various cascades.

Protein synthesis. The counterbalance to protein degradation in muscle cells is protein
synthesis. As stated previously, when degradation exceeds synthesis over time, atrophy
occurs. Signals for protein synthesis include many stimulatory factors such as mechanical
loading of the muscle, hormone circulation, and nutrition. Conversely, protein synthesis
signaling is inhibited by fasting, augmentation of growth factor release or binding, and
muscular disuse. Many proteins play a role in the synthesis pathway but the previously
mentioned mammalian target of rapamycin (mTOR) is consistently viewed as the major
regulator of this process.
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Two functional complexes are formed from mTOR termed mTOR complex-1 and
mTOR complex-2 (mTORC1 and mTORC2). Although both mTORC1 and mTORC2
have a unique role, both complexes will be encompassed and referenced as ‘mTOR’ for
the scope of the current review. Signaling from extracellular growth factors, such as IGF1 and insulin, and amino acids (specifically branched-chain amino acids) lead to the
activation of the PI3K/AKT pathway that is associated with the activation of mTOR (80).
Mechanical loading via resistance exercise of the skeletal muscle also activates this
pathway to activate mTOR (27, 103).
Activated mTOR interacts with many downstream effectors including two wellestablished proteins in particular, S6 kinase (S6K) ribosomal protein and eukaryotic
translation initiation factor-4 (eIF-4E) binding protein (4E-BP) (94). The phosphorylation
of 4E-BP by mTOR allows the unbinding and activation of eIF-4E. Similarly, other eIFfamily proteins are activated with the phosphorylation and activation of S6K by mTOR.
These signaling cascades increase translation initiation rates and thus, overall protein
synthesis.
Speculatively, one could assume during skeletal muscle atrophy the rates of
protein synthesis would decrease due to the lack of loading stimuli. In this case you could
also assume you would observe diminished mTOR signaling. However, results from You
et al. revealed an increase in mTOR activity after 7 days of hind limb immobilization in
mice (161). Similarly, in a mouse hindlimb unloading model, Liu and colleagues
observed increased 4E-BP binding and decreased eIF-4E activation (decreased protein
synthesis) after 3 days and diminished binding and enhanced eIF-4E activation (increased
protein synthesis) after 14 days. These results may be due to a compensatory or safety
11

mechanism in which protein synthesis signaling is induced to protect or save the muscle
tissue from wasting after prolonged periods of disuse. Furthermore, as noted previously,
during muscle atrophy we observe a decline in normal muscle tissue morphology and
function. With variation in protein synthesis during atrophy, it appears the degradation
process accompanying muscle disuse and the associated atrophy may outweigh any
countering protein synthesis that is occurring.
However, the balance of synthesis and degradation lies at the foundation of the
muscle cell net protein status. Therefore, the synthesis status of muscle is still a heavily
weighted component when considering atrophy. For example, when we observe increases
in AMPK, signaled by reduced cellular ATP levels, the result is an associated
inactivation of mTOR (110). Speculatively, reduced mitochondrial function results in
decreased cellular ATP and the activation of AMPK with the inactivation of mTOR. This
inactivation may further shift the balance of the muscle tissue towards an atrophic state,
with the mitochondria organelle playing a key role.

Mitochondria and TFAM
Mitochondria are cellular organelles responsible for the production of energy in
the form of ATP and are also being analyzed for their role in skeletal muscle health.
These organelles are believed to be directly descended from pro-bacteria forming an
endosymbiotic relationship with an original eukaryotic host cell, leading to the selfreplicating nature of mitochondria we observe today (60). As mentioned previously, the
three major factors involved in the catabolic and anabolic status of skeletal muscle can be
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greatly affected by ROS. These reactive molecules are specifically implicated in the
abnormal changes of the above pathways during disuse-induced atrophy (102). While
there are many sources of intracellular ROS, the mitochondria organelles appear to be a
major source of a specific ROS called superoxide anion. Certain centers in the electron
transport chain may leak electrons, which can reduce oxygen molecules to form
superoxide anion (144). The rate at which this leaking of electrons can occur varies
during acute events as well as a during chronic events. Many pathological states,
including disuse-atrophy, are correlated with disproportionate superoxide anion
accumulation leading to excessive oxidative stress (14).
Excessive ROS will activate degradation and apoptotic pathways and must be
neutralized by antioxidants to prevent abnormal cellular degradation. In the case of
superoxide anion, dismutation can occur in the presence of a family of particular
antioxidants called superoxide dismutases (SODs). SODs will catalyze the reaction of
superoxide anion to hydrogen peroxide, which can then be further reduced to water in the
presence of glutathione peroxidase (144). SOD-1 typically catalyzes this reaction in the
cell cytosol while SOD-2 (also called mtSOD) does this in the mitochondria. The
presence of increased superoxide anion without the appropriate increase in SOD-2 could
result in the deleterious effects of oxidative stress in the mitochondria, and may be
specifically linked to mtDNA.

MtDNA. The maternal genetics create the mitochondrial lineage of most animals (17).
Upon fertilization, paternal mitochondrial DNA (mtDNA) is selectively degraded by a
mitochondrial endonuclease. Along with protease and autophagy mechanisms, this
13

degradation leads to mitochondria from the paternal side being effectively abolished,
allowing for maternal mtDNA to replicate and normal development of the organism
(163).
MtDNA is a double-stranded, circular genome located in the inner mitochondrial
matrix of the organelle, compartmentally separate from the nuclear DNA of the cell.
MtDNA is approximately 16.5 kilobases coding for 37 genes. Thirteen of these genes
encode functional subunits of the electron transport chain which are essential for
oxidative phosphorylation (OXPHOS) (12, 60). Twenty-two genes encode transfer RNAs
while 2 genes encode ribosomal RNAs, all of which are involved in the synthesis of
mitochondrial proteins. The remaining protein of the mitochondria requires nuclear DNA,
cytosolic translation, and effective import into the organelle.
MtDNA is essential to maintain energy homeostasis in the organism. Defects in
mtDNA are associated with a multitude of mitochondrial related diseases and phenotypes
such as diabetes, cancer, aging, and cardiovascular disease (13, 60, 149) While many
diseases may not originate in the mitochondria, there may still be an element of
mitochondrial dysfunction involved in the disease genesis or progression. Alterations in
the mitochondrial genome change the morphology and physiology of specific tissues. In
skeletal muscle, Gehrig et al. observed a fiber-type switching from type I and more
oxidative muscle fibers towards type II and more glycolytic muscle fibers in humans with
mitochondrial myopathy (42). This type of mitochondrial defect changes the form and
function of skeletal muscle leading to variations in the predominant energy sources used,
increased muscle weakness, and decreased muscle health by a loss of oxidative capacity.
These abnormalities of mtDNA occur in a variety of ways including DNA methylation,
14

DNA variants, reactive oxygen species (ROS) interactions, and transcriptional machinery
defects. The consequence of these issues affects mtDNA copy number availability and
interrupts typical synthesis of proteins in this organelle (132). In the skeletal muscle of
aging humans, increases in mtDNA mutations and decreases in mtDNA copy numbers
has been observed (127) and is typically associated with decreases in muscle mass
(atrophy) and function. If the synthesis of mitochondrial and OXPHOS proteins is
disrupted by an abnormality or a decrease in mtDNA copy number, a decrement in the
efficient production of ATP (147) and the overproduction of ROS occurs. This increase
in ROS further associates with mtDNA and leads to greater mutation and degradation
creating a disturbance in energy homeostasis and an increased potential for association
with disease. Excess ROS is also implicated in the activation of protein degradation and
apoptosis pathways in muscle through ubiquitin-proteasome and caspase pathways,
respectively (129, 141). An unbalanced increase in these pathways is highly correlated to
skeletal muscle atrophy (16) and depicted in Figure 3. Therefore, we conclude
maintaining the mtDNA structure and mtDNA copy number to transcribe mitochondrial
proteins are vital components of proper health and function in skeletal muscle.

TFAM. As indicated in the literature, the protein responsible for maintaining properly
functioning mtDNA is mitochondrial transcription factor A (TFAM) (79). TFAM is a
diversely operating protein playing a role in mtDNA transcription, organization, and
maintenance. Lack of this transcription factor in systemic TFAM knockout mice resulted
in severe mtDNA depletion and embryonic lethality (134). A 2004 study using a
combination of TFAM overexpression and knockout mice reveals mtDNA copy numbers
15

Figure 2. Disuse leads to atrophy. Flow chart of connecting muscle unloading and
disuse to net protein loss and atrophy indicating mitochondrial dysfunction and redox
imbalance being associated with this process.
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and embryonic lethality (134). A 2004 study using a combination of TFAM
overexpression and knockout mice reveals mtDNA copy numbers are directly
proportional to TFAM levels (31). Overexpression of TFAM in cardiac myocytes in a
transgenic mouse model increased mtDNA copy number and diminished pathological
hypertrophy after myocardial infarction. This subsequently led to an increase in survival
rate (38). These studies provide evidence in an initial link between TFAM and mtDNA.
TFAM is a low molecular weight molecule (~25 kDa) with non-specific DNA
binding properties encoded in the nucleus and transcribed in the cytosol as a pre-protein.
From here, it is shuttled to the mitochondrion by a complex of cytosolic heat shock
proteins (HSPs), HSP60 and HSP70, that act as protective chaperones and as a guide to
locate the mitochondria. HSP protection prevents phosphorylation, promotes proper
folding, and deters degradation during transport (79). The HSP60/HSP70 complex and
attached pre-protein then bind to specific cytosolic receptors located on the translocase of
the outer membrane complex (TOM) of the mitochondria, which serves as a main entry
point for many mitochondrial proteins (107). The TFAM pre-protein will, next, pass from
the TOM, through the intermembrane space, to a channel of the translocase of the inner
membrane (TIM), specifically TIM23, using the selectivity of this complex for positively
charged molecules (121). Entry into the matrix is achieved first by the binding of a
mitochondrial heat shock-protein chaperone, mitochondrial HSP70, to TIM23 at a
specific docking site (TIM44). TIM44-associated HSP70 causes conformational changes
in HSP70 that either passively traps or actively pulls TFAM to the chaperone, as the
precise mechanism is not completely understood (122). A mitochondrial processing
peptidase (MPP) will cleave off the targeting sequence of the pre-protein on the matrix
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side of TIM, while a chaperone, mtHSP60, along with mtHSP70, will re-fold the protein
into its mature form inside of the matrix (50). Again, in the inner mitochondrial matrix,
the mitochondrial heat shock protein complex mtHSP60/mtHSP70 serves as a protector
of TFAM from degradation. Specifically, the mitochondrial protease, LON, selectively
degrades oxidatively modified and improperly folded TFAM unbound to mtDNA (89).
After effective transport into the matrix, properly folded TFAM is able to come into close
proximity with mtDNA. The process of TFAM import is shown in Figure 4.

TFAM binding: mtDNA transcription initiation and protection. Free mtDNA and free
TFAM are both rapidly degraded in the matrix. As mentioned previously, mtDNA
interacting with ROS promotes a decrease in mtDNA copy number and unbound TFAM
is cleaved by Lon protease. TFAM interacting with mtDNA will form a protein-DNA
complex known as a mitochondrial nucleoid which prevents the degradation of each
component (70). This complex forms these nucleoid structures as TFAM binds and coats,
potentially, the entire mitochondrial genome. This provides the structural stability of the
mtDNA. Ekstrand et al. revealed that the levels of total TFAM were directly proportional
to the number of mtDNA copies in a mouse embryo model (31). Further, work done by
Larsson, et al., revealed that heterozygous TFAM depletion resulted in 35-40% decreases
in mtDNA copy numbers while homozygous TFAM depletion resulted in embryonic
lethality due to severe depletions of mtDNA copies and OXPHOS (82). These results
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Figure 3. TFAM import. Process of mitochondrial import of TFAM. The process begins
at number “1” in which TFAM mRNA is transcribed from nuclear DNA and ends at
number “7” where TFAM binds mtDNA, protecting it from mutation.
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FIGURE 3
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provide strong evidence of the correlation of TFAM and mtDNA and supports the role of
TFAM preventing degradation of mtDNA.
TFAM will abundantly bind mtDNA both specifically and non-specifically. Two
distinct promoter regions of mtDNA, light strand promoter (LSP) and heavy strand
promoter 1 (HSP1), are bound by TFAM while other non-distinct regions of the
mitochondrial genome are also able to bind. The specific binding of TFAM to these
promoter regions activates transcription of the genome.
Specific binding of TFAM upstream of promoter sites induces bending of the
genome and recruitment of transcriptional machinery. Two high mobility group-box
domains (HMG-box A and HMG-box B) insert into grooves on the LSP, HSP1, or nonspecific regions of mtDNA. These insertions cause distortion of the mtDNA and result in
bending (100). Bending allows TFAM to interact with the transcriptional machinery,
specifically mitochondrial RNA polymerase (POLRMT). POLRMT has sequence
specific binding to TFAM and mtDNA promoter regions as well as upstream regions.
This complex encourages binding of mitochondrial transcription factor B2 (TFB2M),
resulting in a single RNA precursor in the mitochondrion and is the initiation of
transcription (77). This process further advances to transcription elongation, transcription
termination, initiation of translation, and translation elongation ultimately resulting in the
synthesis of mature mitochondrial proteins (138). While the majority of mitochondrial
proteins are nuclear encoded and require organelle import, intramitochondrial protein
synthesis is still a highly necessary process to ensure proper function and maintenance of
the mitochondrion and the OXPHOS system. TFAM is a key regulator of this process.
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Interventions to improve mitochondrial dysfunction and promote normal function
have been widely studied. Treatments include pharmacologic, nutritional
supplementation, and exercise prescription. These treatments generally attempt to
modulate one or more of the various signaling pathways involved in the creation of
mitochondrial proteins, also termed mitochondrial biogenesis, to counteract dysfunctional
effects (65, 84, 119). The effects of exercise specifically correlate with an increase in
transcription factors of the mitochondria in skeletal muscle. A 90-minute bout of
endurance exercise in mice increased nuclear encoded and mitochondrial encoded genes
involved in mitochondrial biogenesis including key transcription factors and signaling
proteins (119). Furthermore, a study inducing contractile activity of the rat tibialis
anterior muscle by electrical stimulation revealed a significant increase in TFAM, a
mtDNA regulatory protein. The stimulation increased TFAM mRNA levels after four
days of stimulation while also increasing mitochondrial TFAM protein levels and
mitochondrial specific enzymes after 5 days (44). This indicated TFAM expression is
connected to the creation of new mitochondria with exercise. Thus, this project will
emphasize the role of exercise in inducing mitochondrial biogenesis pathways associated
with TFAM as a mechanism to preserve mtDNA and protect skeletal muscle tissue from
atrophy.

Exercise
Exercise enhances physical performance and is well known to be associated with
many positive health benefits (155). A single bout of exercise causes a change in
molecular expression in muscle that promotes specific adaptations. If the appropriate
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duration, frequency, and intensity of contractile activity in muscle tissue occurs from
physical exercise, specific signaling mechanisms will ensue, leading to the tissue
adapting to the demand of the physical stress. Levels of circulating inflammatory
markers, growth factors, and adrenergic compounds also increase during exercise.
Exercise induces phenotypic changes of the muscle that include increased cross-sectional
area, increased capillary density, fiber-type transitioning, and mitochondrial biogenesis
resulting in increased mitochondrial density of the muscle cell (41, 159). This increased
mitochondrial density is a part of an adaptive process allowing the organism experiencing
the stress of exercise to increase functional proteins involved in the creation of energy
(mitochondria and the OXPHOS system) to handle that specific stress in the future. A
key component of exercise-induced mitochondrial biogenesis occurs via the effects of
skeletal muscle contraction and the upregulation of TFAM (44).
For a skeletal muscle to contract, an action potential(s) must propagate from the
motor cortex, through nerve fibers of the central nervous system, synapse at motor
neurons located on the spinal cord down to the neuromuscular junction (NMJ). The signal
must cross the NMJ and further propagate across the sarcolemma of the muscle and down
into the t-tubules where voltage-gated dihydropyridine receptors (DHPRs) are able to
interact with ryanodine receptors. Ryanodine receptor activation releases calcium from
the sarcoplasmic reticulum (SR) into the cytoplasm of the muscle cell (115). From there,
calcium can bind to troponin and remove tropomyosin from active binding sites of actin
contractile proteins. Finally, in the presence of adequate ATP, muscle contractions can
occur by the recycling of cross-bridging between myosin and actin proteins. During
exercise, potentially high rates of this “excitation-contraction coupling” process occurs.
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The release of calcium from the SR as well as the increased demand for ATP in this
process leads to significant molecular changes within the cell.
The amount of cytosolic calcium released from the SR in skeletal myocytes
during contraction not only depends on duration, frequency, and intensity of exercise of
the muscle but also on the muscle fiber type. Isolated single muscle fiber calcium has
been measured previously to be concentrated in the range of 30-50 nM. Upon
stimulation, type I (slow-twitch) muscle fibers produced concentrations between 100-300
nM of calcium while type II fibers (fast-twitch) are capable of a drastically higher (~10x)
1-2 µM range (43). Baylor and colleagues report fast-twitch fibers capable of 3-4 times
the amount of slow twitch (6). Nonetheless, cytoplasmic calcium concentrations in
contracting fast-twitch muscle appear to be much greater than slow-twitch. This is
important because specific types of exercise requiring higher relative intensities and
perhaps longer relative durations recruit type II fibers at a greater rate than lower
intensity exercise and disuse of the muscle (76). This leads to high levels of cytosolic
calcium and increased intracellular signaling. Specifically, increased calcium activates
calcium/calmodulin-dependent protein kinases (CAMKs) that are linked to increases in
mitochondrial biogenesis (15, 19).
Increasing the intensity of physical activity also increases the AMP/ATP ratio in
skeletal muscle (74, 153). As the previously described contraction process takes place
and the cellular energy demand increases, the use of phosphate groups from ATP
increases the amount of ADP and AMP, thus increasing the AMP/ATP ratio. AMP
interacts with an AMP-activated protein kinase (AMPK) that is interrupted by high levels
of ATP (48). The β-subunit of AMPK has a glycogen binding domain that, when bound,
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inhibits the activation of AMPK (90). Exercise not only increases the AMP/ATP ratio but
also depletes muscle glycogen, potentially releasing and activating AMPK. For these
reasons AMPK is a cellular energy sensor and has been characterized as a “master
switch” of metabolism (59). In response to exercise, activation of AMPK leads to
downstream activators of mitochondrial biogenesis (8, 125).
Exercise will also acutely increase the levels of ROS in muscle (25). ROS has
been implicated in many health disorders including muscle myopathies (95). The major
contributors to ROS in skeletal muscle include xanthine oxidase (XO), NADPH-oxidases
(NOXs), and mitochondria. In mitochondria, ROS production occurs due to electron
leakage in the electron transport chain (ETC) (47). The ETC passes electrons through a
series of protein complexes along the inner mitochondrial membrane with oxygen being
the last acceptor of the electron. As oxygen accepts electrons in the ETC, it typically
results in the formation of water. Oxygen that undergoes incomplete reductive processes
results in radicals and the potential formation of ROS. Complex I and Complex III of the
ETC appear to be the greatest contributors of ROS in the mitochondria. Although the
precise contributions of each is poorly understood, these locations in muscle cells
produce oxidants that are capable of negatively affecting cellular function while also
activating potentially beneficial signaling pathways. An example of this was
demonstrated in which male Wistar rat groups performed exercise and ate high
antioxidant diets. The groups eating high antioxidant diets revealed decreased levels of
mitochondrial biogenesis markers, regardless of exercise, indicating a potentially
negative outcome of decreasing ROS signaling (135). The maintenance and balance of
ROS through antioxidant defense systems and adaptations to the mitochondria are
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important factors in skeletal muscle health and control potential mitochondrial biogenesis
signaling.
Other major signaling mechanisms of exercise and mitochondrial biogenesis
include the increased levels of inflammatory markers, epinephrine, and growth factors.
Markers such as interleukins (IL-1,6) and tumor necrosis factor-alpha (TNF-α) bind
cellular receptors and lead to increases in ROS production (73). Adrenal glands release
epinephrine in response to exercise. Speculatively, this could be because of both the
physical stress that is perceived as well as an emotional response that potentially occur
during more intense forms of exercise, causing the release of epinephrine. Binding of
epinephrine to β-adrenergic receptors of the cell lead to increases in cyclic AMP (cAMP),
involved in biogenesis pathways. Growth factors such as insulin-like growth factor-1
(IGF-1) and insulin enter the cell and activate protein synthesis pathways, also implicated
in the creation of mitochondrial proteins (93).

Exercise and TFAM connection. The various effects of skeletal muscle contraction and
the stress of exercise connect to mitochondrial biogenesis in several ways. These
upstream signals converge downstream to ultimately increase TFAM transcription. This
convergence point is a major link of exercise to mitochondrial biogenesis and has
received a great deal of attention in the literature and is known as the peroxisome
proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1α) and is activated in a
multitude of ways (35, 105, 137).
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PGC-1α is a transcriptional coactivator with formidable evidence of its correlation
to exercise. Endurance exercise increases levels of PGC-1α in rat soleus muscle 18 hours
post-exercise (137). Kang et al. subjected female Sprague-Dawley rats to anaerobic
sprinting exercise and noticed a 5.6-fold increase in PGC-1α in the exercise group
compared to the controls (68). Another group subjected rats to 20 minutes of aerobic
treadmill running and increased PGC-1α mRNA levels 1.5-5 fold in soleus and
gastrocnemius muscles while also noting 6 weeks of chronic exercise increased PGC-1α
mRNA levels by ~25% in rat soleus muscle (10).
The aforementioned increase in cytosolic calcium with exercise activates CAMK
which upregulates PGC-1α (15). CAMK is also a potent activator of myocyte-enhancer
factor-2 (MEF2) (91). MEF2 is capable of binding to the nuclear promoter regions of the
PGC-1α gene, enhancing its transcription (85). As AMP levels increase due to the
demand of physical activity it interacts with AMPK, which also directly activates PGC1α (125). ROS increases during exercise activate p38 mitogen-activated protein kinase
(p38MAPK) that upregulates PGC-1α (3). ROS signaling also includes the activation of
AMPK indirectly, although it is possible this is due to the decrease in ATP associated
with stressful events (53). While ROS signaling leads to biogenesis of mitochondrial
proteins, excessive ROS is detrimental to the cell. Furthermore, silent mating type
information regulator 2 homolog (SIRT1) upregulation due to increased levels of
nicotinamide adenine dinucleotide (NAD+) caused by exercise will deacetylate PGC-1α
leading to its activation (131). Epinephrine released in response to exercise increases
adenylyl cyclase leading to increased cAMP. A cAMP dependent protein kinase (PKA)
activates with increased cAMP, and further interacts and upregulates cAMP response
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element binding protein (CREB) that plays a role in PGC-1α upregulation. Growth
factors (GFs) such as IGF-1 and insulin, as well as mechanical loading of muscle,
activate mammalian target of rapamycin (mTOR), a major protein synthesis pathway that
also promotes PGC-1α activation (21, 94).
PGC-1α is able to co-activate nuclear respiratory factors (NRFs), specifically
NRF-1 and NRF-2, nuclear transcription factors responsible for activating many
mitochondrial proteins (143). When this occurs, TFAM mRNA is transcribed from the
nuclear genome by NRFs where it is able to be exported to the cytosol for translation,
imported into the mitochondria, and maintain mtDNA and activate transcription of
mitochondrial proteins (refer to Figure 4).
An exercise stimulus is a powerful metabolic signal, as shown above, that
activates a multitude of signaling pathways in skeletal muscle leading to the transcription
of TFAM, a key modulator of mitochondrial biogenesis. For these reasons, exercise and
TFAM are attractive variables to study in skeletal muscle pathology. The above signaling
pathways connecting these variables are summarized in Figure 5.

Skeletal Muscle Protection
Exercise induces a hormetic response in animals. That is, an appropriate dose of
exercise over time leads to beneficial cellular adaptations to withstand the stress of
exercise. This process of adaptation is at the essence of evolutionary biology. At extreme
or high dosages, exercise can be toxic. When appropriate dosages of exercise are applied
to an organism, the hormetic response plays a role in the prevention of pathological
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Figure 4. Exercise leading to TFAM. Schematic representing multiple signaling
pathways created by exercise converging on PGC-1α, which co-activates with NRF-1 and
NRF-1. This coactivation results in the recruitment of transcriptional machinery to
nuclear DNA, and ultimately transcribed TFAM mRNA. Through processes described
above, translated TFAM is imported into the mitochondrion where it can interact with
mtDNA.
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conditions. Exercise has been suggested to increase mitochondrial volume by up to 40%
(87). This is due to factors of mitochondrial biogenesis being increased with exercise,
signaling the increase in mitochondrial proteins to be synthesized (refer to Figure 2). In
aging skeletal muscle, a rapid decline in muscle mass and muscle performance
parameters are observed as are decreases in mitochondrial volume and biogenesis.
Moderate exercise reverses or attenuates the decline in mitochondrial biogenesis markers
and reduce the age-associated reduction in skeletal muscle mass (75). Although aging is
its own respective form of skeletal muscle atrophy, this elucidates the idea that exercise is
able to reverse the effects of atrophy through the induction of mitochondrial biogenesis.
The type of exercise, volume, intensity, and frequency as well as genetic
capabilities of the organism will ultimately determine the extent to which muscle cells
will adapt. Athletes that undergo intense physical exercise, especially endurance training,
drastically increase the amount of mitochondrial proteins, antioxidant defense, and
oxidative capabilities as an adaptation that more efficiently produces ATP to meet the
demands of training. Those participating in lower levels of exercise and physical training
will also increase mitochondrial proteins and efficiency (75), but generally to a lesser
degree as stress is reduced and does not require higher levels of adaptation to meet the
energy demand of the cell. With increased mitochondrial capabilities from exercise
training, muscle cells will have a greater capacity to produce ATP and greater antioxidant
scavenging enzymes (133). This adaptation allows the muscle cells to withstand larger
levels of stress that would be incurred through physical training by a specific mechanism
of reducing and neutralizing ROS. As stated previously, increased ROS activates many
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pathways that cause skeletal muscle cellular proteins to be degraded, resulting in a net
loss of protein over time and in the appearance of the negative effects of atrophy.
If the previously discussed processes that contribute to protein degradation, cell
apoptosis, and variation in protein synthesis signaling in skeletal muscle atrophy are
diminished during an atrophic setting, a reduction in atrophy is observed. Electronic
stimulation of muscle tissue causing contraction throughout a 14 day hindlimb
suspension protocol resulted in significant increases in soleus muscle mass compared to
controls and to an increase in Bcl-2, preventing mitochondrial release of CytC and
apoptosis (46). As we know, contractile activity, as occurs in exercise, also stimulates
mitochondrial biogenesis and protein synthesis potentially leading to these results. The
administration of branched chained amino acids (BCAAs) throughout a 14-day hindlimb
suspension model of male Wistar rats diminished atrogin-1 and murf-1 protein expression
and prevented a decrease in soleus mass (56). BCAAs are known to activate mTOR
pathway signaling and protein synthesis while reducing degradation, resulting in the
protection of muscle mass, while mTOR activation is implicated in mitochondrial
biogenesis (Figure 2). In aging mice overexpressing catalase, a ROS reducing enzyme in
the mitochondria, an improvement in muscle performance and lowered protein oxidation
was observed compared to aged control mice indicating a crucial role for mitochondrial
function protecting skeletal muscle (146).
The results above clearly indicate that different methods associated with
improving mitochondrial function are capable of improving or preventing skeletal muscle
loss during atrophy. A question that remains is whether or not the skeletal muscle can be
protected from atrophy by interventions that occur prior to the atrophic setting? The
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abundance of evidence suggesting a correlation between mitochondrial dysfunction and
atrophy indicate it may be beneficial to target mitochondrial biogenesis to mitigate excess
ROS and alleviate the dysfunction of mitochondria and the efficiency of ATP production
as a mechanism to diminish the processes of atrophy. If the muscle cells’ adaptations can
be sustained for any significant time during a period of unloading, atrophy may be at least
diminished.
Fujino et al. analyzed soleus muscle mass in rats after 1 session of endurance
exercise prior to HLS. This group exercising for one session prior to suspension trended
higher than the suspension group without exercise in soleus muscle mass, although no
significant differences were determined (37). These authors also noted a reduction in
MHC I, a slow myosin heavy chain, protein expression after 14 days of HLS while the
exercise prior to HLS group trended higher but not significantly. However, one exercise
session may not be sufficient stress to induce adequate adaptive changes to provide
significant protection of the muscle over an HLS protocol. A typical beginner exercising
animal generally will not exercise completely during its first session, as it has not become
familiarized to the procedure. Multiple training sessions over time allow the animal to
understand the demands of the procedure while also allowing an exercise protocol to be
applied that emphasizes a progression over time, leading to a compounding and an
increased level of adaptation. These heightened adaptations could be key in protecting the
muscle from atrophy during unloading and disuse.
Another group used swimming exercise, 3 sessions a week for 4 months, on
female Wistar rats before immobilizing a hindlimb for 14 days to assess the effect of
exercise on rehabilitation of atrophied skeletal muscle. The exercise prevented loss of
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soleus muscle mass compared to rats that did not exercise. A feature of the present study
was the use of swimming exercise, common in rehabilitation programs, as it does not
load particular areas of the body that were injured previously while still allowing the
muscle to contract. This also disallows increased mechanical loading that would be
experienced in land based exercise, potentially providing different results. Furthermore, 4
months of exercise training may be difficult to retain adherence in humans. The question
regarding shorter training protocols used to prevent muscle loss remains. Although this
study used an immobilization protocol to induce atrophy, it does indicate a possible role
of exercise in preventing atrophy during acute disuse.

TFAM and skeletal muscle protection. Mitochondrial biogenesis and function require
TFAM to protect mtDNA from ROS and degradation while activating mtDNA
transcription of specific proteins. TFAM proteins precede activity of mitochondrial
biogenesis. Electrical stimulation of rat muscle at 10 Hz for 3 hours/day resulted in an
initial 55% increase in TFAM by day 4 of stimulation. This was followed by a significant
import of TFAM into intermyofibrillar mitochondria by day 5 and 7 and increased import
protein machinery content. Further, by day 7 TFAM binding to the mitochondrial
promoter increased 49%, the mitochondrial transcript cytochrome c oxidase (COX) III
subunit protein content increased 65%, and COX enzyme activity increased by 72% (44).
This study reveals a time schedule of TFAM preceding mitochondrial biogenesis
processes and the intricate role TFAM plays in mitochondrial biogenesis that occurs
during skeletal muscle contractile activity. Contractile activity occurs in exercise, and
thus, the data of this study promotes further connection of TFAM and exercise.
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Exercise creates an internal environment producing many signals inducing
mitochondrial biogenesis. The activation of PGC-1α is of particular importance, as it is a
convergence point of many of the signaling cascades activated by exercise. Kang et al.
overexpressed PGC-1α in the tibialis anterior muscle of mice through in vivo transfection
before immobilizing a randomly selected hindlimb for 14 days followed by 5 days of
remobilization creating an acute period of unloading and disuse of the musculature. After
7 and 14 days of immobilization, control mice revealed a steady decline in PGC-1α and
TFAM mRNA expression levels. PGC-1α overexpression resulted in a decrease in ROS,
increase in mitochondrial functional markers, and reduction in inflammatory markers
after immobilization and remobilization of the muscle. There was also an increase in
mtDNA and mitochondrial density. This resulted in the preservation of soleus muscle
mass after remobilizing previously immobilized muscle (69).
Cannavino et al. noted reductions in PGC-1α and mitochondrial complexes after 7
days of hindlimb unloading in mice. This reduction was associated with soleus skeletal
muscle atrophy. The group further overexpressed PGC-1α in a transgenic mouse model
and subjected these mice to a similar 7 days of hindlimb unloading. The overexpression
of this gene prevented catabolic systems, reduced ROS, retained oxidative metabolism,
and protected soleus muscle mass from atrophy caused by hindlimb unloading (14).
With the increase in TFAM being a downstream product of upregulating PGC-1α,
the results of increased mtDNA copy number, mitochondrial density, and mitochondrial
function are expected. Here we see creating a condition, i.e. overexpressing PGC-1α,
correlating with TFAM and mitochondrial biogenesis prior to an atrophic protocol in
skeletal muscle resulting in the protection of muscle. With TFAM being transcribed in
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direct response to increased PGC-1α, the question of the importance of TFAM
overexpression alone in skeletal muscle protection remains. The use of TFAM transgenic
mouse models in the analysis of disuse-induced skeletal muscle atrophy has, to the best
of our knowledge, not been previously shown. However, while the research using TFAM
manipulations are scarce, there is data available to begin to analyze the effects of TFAM
changes in different areas.
A germ line disruption of the mouse TFAM (TFAM -/-) gene leads to extreme
decreases in mtDNA and embryonic lethality (111). Nishiyama and colleagues mated
transgenic mice overexpressing TFAM with mice of a mitochondrial disease model
containing mutant mtDNA. This resulted in the amelioration of mitochondrial disease and
prolonged lifespan by increasing mtDNA copy number due to the effects of
overexpressing TFAM (101). A 2004 study using a combination of TFAM
overexpression and knockout mice reveals mtDNA copy numbers are directly
proportional to TFAM levels (31). These studies establish highly specific correlations
between TFAM, mtDNA, and potential pathology.
A mouse model with skeletal-muscle specific disruption of TFAM leads to
mitochondrial myopathy, ragged-red fibers, reduced muscle force, abnormal
mitochondrial shape, and decreased respiratory chain activity (157). Iyer et al. report an
in vivo treatment with recombinant TFAM results in increased motor endurance and
complex-I respiration in mice (54), with both studies linking TFAM directly to skeletal
muscle health decrements and reduced mitochondrial function. However, treating specific
pathological conditions using TFAM overexpression are scarce.
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Fujino et al. overexpressed a recombinant form of human TFAM (rhTFAM) in
cultured cardiac myocytes. This rhTFAM rapidly entered the mitochondria and increased
mtDNA copy number. Electron transport chain proteins (COX I and COX III) were
elevated, as they are mtDNA encoded while nuclear DNA encoded proteins were not
significantly elevated. Overexpression of rhTFAM also attenuated pathological
hypertrophy by blocking the activation of nuclear factor of activated T-cells protein,
known to induce pathological hypertrophy in cardiac myocytes (38). Again, the data
shows a correlation between mtDNA copy number and attenuating pathology with this
example being in cardiac muscle cells, implicating the possibility of TFAM
overexpression in the treatment of mitochondrial related pathologies in skeletal muscle
cells.
Similarly, Ikeda et al. used transgenic mice overexpressing TFAM in a volumeoverload induced heart failure model to observe the effects of upregulated TFAM on
cardiac muscle after myocardial infarction. TFAM mice exhibited improved cardiac
function, diminished pathological hypertrophy, and a reduction in cardiac muscle ROS
compared to control, heart failure mice. Mitochondrial enzymatic activity did not decline
in the TFAM model, as is seen with the control heart failure mice. This group also used
rat isolated cardiomyocytes to show an increase in mitochondrial ROS resulted in an
increase in harmful, degrading proteinases (metallomatrix proteinases, specifically MMP2 and MMP-9). Myocytes overexpressing human TFAM resulted in increased mtDNA
copy number and a suppression of mitochondrial ROS and proteinase activity (51). The
results of this study indicate TFAM increases mtDNA copy number in cardiac muscle
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while also limiting oxidative stress. This also implicates a potential use in skeletal muscle
to treat ROS-induced pathological conditions, such as atrophy.
Ikeuchi’s group induced heart failure via myocardial infarction after ligation of
the left coronary artery in wild-type and TFAM transgenic mice. TFAM mice had an
attenuation of left-ventricular remodeling and failure as well as no reduction in
mitochondrial complex activity compared to wild-type mice. Furthermore, TFAM mice
had a higher survival rate compared to wild-type even with similar infarct sizes. Results
here provide further evidence in the potential use of TFAM to treat pathological
conditions in muscle tissue.

Summary. The literature discussed above shows that exercise induces mitochondrial
biogenesis and function, efficient mitophagy, and increases the cell’s ability to create
ATP and neutralize ROS. These adaptations have been shown to reduce cell apoptosis,
increase growth and protein synthesis signaling, and decrease protein degradation
pathways. Beneficial changes such as these are all in opposition to the disuse-induced
skeletal muscle atrophic state. Therefore, multiple questions are raised given these
premises: Will exercise training as a treatment prior to a disuse-induced atrophic scenario
provide a protective benefit to skeletal muscle?; and if so, is the protective mechanism
associated with changes in markers of mitochondrial biogenesis and function?
Furthermore, the above literature also reveals protective effects of PGC-1α during disuseinduced atrophy and shows beneficial effects of TFAM overexpression in
cardiomyocytes during pathological scenarios that creates further research questions: If a
major molecular signaling mechanism to transcribe TFAM is via PGC-1α, then will
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overexpressing TFAM provide a similar protective benefit to skeletal muscle during an
atrophic scenario?; If overexpressing TFAM is beneficial in cardiomyocytes, will the
same benefit occur in skeletal muscle during disuse-atrophy? Finally, if both TFAM
overexpression and exercise protect skeletal muscle, will combining both treatments have
a synergistic effect? These research questions derived from evidence in the literature led
to the development of multiple studies to attempt to address if exercise and TFAM
prevent skeletal muscle atrophy. Refer to Figure 5 for a summary schematic of the
proposed research.
Much of this chapter is published as a review article and is referenced as follows:
Theilen NT, Kunkel GH, and Tyagi SC. The Role of Exercise and TFAM in Preventing
Skeletal Muscle Atrophy. J Cell Physiol 232: 2348-2358, 2017.
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FIGURE 5. Summary figure. A graphical representation of what this project intends
analyze: 1. This project intends to observe if exercise prior to a disuse-induce atrophic
event will prevent atrophy.; 2. With exercise knowingly increasing PGC-1α and TFAM,
will these mechanisms be associated with redox balance that, when imbalanced, has been
previously shown to induce degradation and apoptosis as a mechanism of exercisepreconditioning preventing atrophy?; and 3. We intend to highlight the TFAM pathway
through TFAM overexpression to see if this molecule is associated with redox balance
and reduced atrophy.
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CHAPTER II
EXERCISE PRECONDITIONING DIMINISHES SKELETAL MUSCLE ATROPHY

Introduction
Skeletal muscle atrophy results in the reduction of skeletal muscle mass and is
associated with a decrease in health and quality of life. As muscle mass declines, the
ability to perform physical tasks is greatly reduced leading to decreased independence
and increased factors of morbidity and mortality (113). The study of associated molecular
pathways is of great importance to understand this condition and guide research in the
development of future therapies.
One cause of skeletal muscle atrophy occurs during prolonged mechanical
unloading and disuse of muscle. This can be due to scenarios such as microgravity,
sedentary lifestyle, bedrest, limb immobilization, and spinal cord injury. Ultimately, each
of these scenarios encompass a lack of mechanical stress and muscle fiber contraction.
Profound losses of skeletal muscle may occur under these conditions. As an example,
many orthopedic injuries and non-orthopedic diseases require bedrest or body
immobilization around the site of injury. An atrophy rate of approximately 0.5% of total
muscle mass per day has been reported in the first 2-3 weeks under disuse atrophy
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conditions (161). Therefore, the need to develop therapies to maintain skeletal muscle
tissue when entering these settings is worth investigation.
Atrophy caused by unloading and disuse is characterized by reductions in size,
weight, and function of the tissue (140). When this occurs, molecular changes leading to
the net loss of functional protein in muscle tissue are observed. Moreover, previous data
indicates correlations between muscle atrophy, mitochondrial dysfunction, and increased
oxidative stress (102, 127). It is well established that excessive reactive oxygen species
(ROS) observed during muscle atrophy activates protein degradation and cell apoptotic
pathways while decreasing protein synthesis resulting in a net protein loss (22, 64, 97).
Similarly, past research reveals ROS also damages functional components of the
mitochondria leading to reductions in physiologic processes and mitochondrial
dysfunction. More specifically, excessive ROS mutates unprotected mtDNA leading to
the translation of defective mitochondrial proteins resulting in mitochondrial dysfunction
(156).
Exercise is a powerful stimulator of mitochondrial function (128). On the
molecular level, exercise activates the master regulator protein of mitochondrial
biogenesis, peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α), via signaling cascades of acute and immediate changes in circulating and cellular
molecules a part of the exercise response such as epinephrine, growth factors, AMP, and
Ca2+ (118). This master regulator co-activates with nuclear-respiratory factors 1 and 2,
increasing the transcription of mitochondrial transcription factor A (TFAM), a wellknown marker positively correlated with mtDNA copy number and mitochondrial
function (148).
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While many studies exist analyzing intra- and post-atrophic setting interventions
to alleviate atrophy, the development of therapies to prevent these negative changes prior
to a setting of unloading and disuse is scarce. When entering a known atrophy-causing
scenario, such as prescribed bedrest or immobilization after elective surgery, being able
to intervene physical or molecularly directed treatments to prevent muscular atrophy
could be extremely beneficial for patient quality of life and in reducing financial burdens
by mitigating medication and rehabilitation costs.
In a previous review of skeletal muscle atrophy, we proposed a protective effect
of exercise prior to an atrophic setting and potential molecular mechanisms associated
(140). Therefore, in the current study we hypothesize exercise training prior to skeletal
muscle unloading and disuse will increase mitochondrial markers and protect skeletal
muscle from atrophy. To test this, we use a 7-day hindlimb suspension (HLS) protocol to
induce muscle atrophy in the hindlimbs of mice compared to mice performing an 18-day
exercise protocol prior to 7 days of HLS. Results indicate exercise increases
mitochondrial markers prior to entering HLS and this preconditioning is associated with
the prevention of skeletal muscle atrophy post-HLS. Exercise is an attractive therapy to
intervene prior to disuse settings.
Methods
Animals and ethical approval. The present study used male C57BL/6J mice (WT). Four
groups of wild-type mice (WT) were used including a control, hindlimb suspension
(HLS), exercise prior to hindlimb suspension (Ex+HLS), and exercise only (Ex). Mice
were sacrificed immediately after HLS treatments and within 48 hours of exercise only
treatments. The mice exercising before suspension were placed in HLS during the same
45

day of their last exercise session. All mice were 13±1 weeks of age at the time of
sacrifice. The mice were purchased from Jackson Laboratory (Bar Harbor, ME) and all
standard procedures and experiments involving animals conformed with the National
Institutes of Health guidelines and were approved by the Institutional Animal Care and
Use Committee of the University of Louisville.

Hindlimb suspension. Mice were suspended by the tail in custom built cages to unload
the hindlimb musculature and induce atrophy for a period of 7 continuous days. Cages
were constructed as previously shown (36). Briefly, mice were first placed under
continuous isoflurane anesthesia while a harness was fashioned to the tail. The tail was
cleaned and surrounded with tape cross-sectionally. A 27-gauge needle cap was cut
down, as to be open on each end, to ~2 centimeters in length. A small hole was drilled
into the sidewall of the needle cap and a piece of nylon string was tied into a loop through
this hole. This cap was then placed on the tail and taped into place roughly 1/3 of the tail
length from the base. The nylon loop could then be attached to the roof of the cage,
suspending the animal’s hindlimbs while allowing the forelimbs to bear weight and the
animal to move around the cage. Mice could also access food and water ad libitum in this
manner. Bodyweights were recorded before and after suspension.

Exercise protocol. Exercise consisted of 14 training sessions over 18 days of treadmill
running in a concurrent style. Mice were acclimated to the treadmill during the first four
sessions. The subsequent 10 sessions consisted of 6 endurance training style exercise

46

sessions and 4 high-intensity interval style exercise sessions. All exercise program details
(Table 1) were matched between exercising groups.

Laser Doppler. Gastrocnemius arterial blood flow imaging was done for each group
using a laser Doppler imaging system (Moor FLPI, Wilmington, DE) to assess flux of the
hindlimb after treatments. Mice were first administered tribromoethanol based on
bodyweight. The musculature of the left, lower hindlimb was then exposed, revealing the
musculature of the leg. Each mouse was placed in a prone position and the laser was
positioned 15 cm from the area of interest. The laser was site directed to a prominent
vessel on the posterior hindlimb, superficial to the gastrocnemius. Recordings of flux
were measured for 2 minutes and quantified.

Tissue extraction and weight. Soleus and gastrocnemius tissues were excised and separated
from each leg in all experimental groups, washed with 50 mmol/L phosphate buffer saline
(PBS) pH of 7.4, weighed individually, snap frozen in liquid nitrogen, and stored at −80°C
until use. All methods and timings of tissue extraction were equated across all groups.
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Table 1. Exercise protocol. Mouse concurrent treadmill exercise protocol consisting of a
“Week 1” acclimation, followed by progressive training “Week 2” and “Week 3”. Three
days per week (M,W,F) consisted of endurance-style exercise while two days per week
(T,TH) consisted of higher-intensity interval sprint style of exercise.
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TABLE 1
WEEK 1
Warmup
Work Rate
Rest
Distance

Monday
OFF

Tuesday
7m/min. for 50m
7m/min.
3min. off/100m
300m

Wednesday
7m/min. for 50m
8m/min.
3min. off/100m
300m

Thursday
7m/min. for 50m
9m/min
3min. off/100m
300m

Friday
7m/min. for 50m
10m/min.
3min. off/100m
300m

WEEK 2
Warmup
Work Rate
Walk Rate
# of Sprints
Rest
Distance

Monday
7m/min. for 50m
11m/min.
3min. off/100m
350m

Tuesday-Sprints
7m/min. for 50m
15m/min. for 10m
7m/min. for 10m
8
5mins after 5 sprints
160m

Wednesday
7m/min. for 50m
12m/min.
3min. off/100m
375m

Thursday-Sprints
7m/min. for 50m
17m/min for 15m
7m/min. for 15m
10
5mins after 5 sprints
300m

Friday
7m/min. for 50m
13m/min.
3min. off/100m
400m

WEEK 3
Warmup
Work Rate
Walk Rate
# of Sprints
Rest
Distance

Monday
7m/min. for 50m
13.5m/min.
3min. off/100m
450m

Tuesday-Sprints
7m/min. for 50m
18m/min. for 15m
7m/min. for 15m
11
5mins after 5 sprints
330m

Wednesday
7m/min. for 50m
14m/min.
3min. off/100m
500m

Thursday-Sprints
7m/min. for 50m
20m/min. for 20m
5x-7m/20m; 6x-7m/10m
11
5mins after 5 sprints
380m

Friday
7m/min. for 50m
14.5m/min.
3min. off/100m
550m
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Immunofluorescence. A portion of each muscle was cut cross-sectionally at the midbelly
and immersed in tissue-freezing medium (Triangle Biomedical Sciences, Durham, NC,
USA) in disposable plastic tissue-embedding mold (Polysciences Inc., Warrington, PA,
USA). The tissue blocks were immediately frozen and kept at -80°C until use. 7-10 µm
thick sections were obtained from each muscle using a Cryocut System (CM 1850; Leica
Microsystems, Buffalo Grove, IL, USA). Tissue sections were placed on Poly-L-Lysine
coated microscope slides (Polysciences, Inc., Warrington, PA, USA). Tissue sections were
fixated in acetone for 20 mins, washed in 1X PBS-T solution, and were incubated with
permeabilization solution (0.2 g Bovine Serum Albumin, 3 ul Triton X-100 in 10ml 1X
PBS) for 1 hour at RT followed by another washing step with 1X PBS-T. The sections
were incubated with primary antibody (anti-Laminin; Abcam, Cambridge, MA, USA)
dilution of 1:200 overnight at 4°C. After washing with 1X PBS-T the slides were incubated
with a fluorescently labeled secondary antibody (goat anti-mouse Alexa flour 594;
Invitrogen, Waltham, MA, USA) with a 1:300 dilution for 1 hour at RT. After another
washing step, slides were mounted with mounting medium and glass cover slips, then
visualized using a laser scanning confocal microscope (Olympus Fluo View 1000; Center
Valley, PA, USA). Cross-sectional area measurements were acquired using laminin images
by hand tracing single, stained muscle fibers in ImageJ software (123).

DHE Staining. After excision, each muscle was cross sectioned in half, immediately placed
in tissue-freezing medium (Triangle Biomedical Sciences, Durham, NC, USA), snap
frozen and stored at -80°C until use. Samples were then sectioned on a cryostat, placed on
slides, and in situ superoxide generation was evaluated in each cryosection with the
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oxidative fluorescent dye dihydroethidium (DHE). Cryosections (10 μm) were incubated
with DHE (2 μmol/l) in PBS. After washing, slides were mounted with mounting medium
and a cover slip, then visualized using a laser scanning confocal microscope (Olympus
Fluo View 1000; Center Valley, PA, USA).

Protein Estimation. Muscle tissue samples were bead-homogenized in ice‐cold RIPA (1
mmol/L) buffer with PMSF and protease inhibitor cocktails (1 μL/mL of lysis buffer,
Sigma Aldrich, St. Louis, MO). The samples were then centrifuged at 12,000 g for 20 min
at 4°C. The supernatant was extracted and stored at −80°C until use. Protein estimation
was measured by the Bradford‐dye (Bio‐Rad, CA) method in a 96‐well microliter plate
against a Bovine Serum Albumin (BSA) standard. The plate was analyzed at 594 nm in a
Spectra Max M2 plate reader (Molecular Devices Corporation, Sunnyvale, CA).

Western Blot Analysis. Protein lysates (40 µg) were prepared and heated at 95°C for 5 min
and loaded in an SDS polyacrylamide gel in running buffer and run at a constant current
(75 Volts). Proteins were then transferred to a PVDF membrane overnight at 120 mA at
4°. After transferring, the membranes were blocked in 5% nonfat milk for 1 hour at room
temperature followed by overnight incubation with primary antibodies (Anti-PGC-1α,
Anti-TFAM, Anti-SMHC, Anti-CS; Abcam, Cambridge, MA, USA.) at 4°C. After
washing with TBS-T buffer, membranes were incubated with secondary antibodies (horse
radish peroxidase- conjugated goat anti-mouse, goat anti- rabbit IgG; Santa Cruz
Biotechnology, Dallas, TX, USA) for 1 hour at RT with 1:5000 dilution followed by
washing. The membranes were developed with an ECL Western blotting detection system
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(GE Healthcare, Piscataway, NJ, USA) and all images were recorded in the gel
documentation system ChemiDoc XRS (Bio-Rad, Richmond, CA, USA). The membranes
were stripped with stripping buffer (Boston BioProducts, Ashland, MA, USA) followed by
a blocking step with 5% milk for 1 hour at RT. After washing, membranes were incubated
with anti-Gapdh antibody (Millipore, Billerica, MA, USA) as a loading control protein.
PGC-1α and SMHC were visualized on the same gel while TFAM and CS were visualized
on the same gel, due to size similarities. The data were analyzed by Bio-Rad Image Lab
densitometry software and normalized to anti-Gapdh bands.

Quantitative PCR. To assess mRNA expression of different genes in skeletal muscle, RNA
was isolated with TRIzol® reagent (Life Technologies, Carlsbad, CA, USA) according to
manufacturer's instructions. The RNA quantification and purity was assessed by nanodrop1000 (Thermo Scientific, Walthan, MA, USA). Aliquots (2μg) of total RNA were reversetranscribed into cDNA using a High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Foster City, CA) according to the manufacturer’s protocol. q-PCR was
performed for different genes (PGC-1α, TFAM, CS, Myh4, Myh7, SOD-1, SOD-2), in a
final reaction volume of 20 µl containing 10 µl of PerfeCTa SYBR Green SuperMix, Low
ROX (Quanta Biosciences, Gaithersburg, MD), 6 µl nuclease free water, 2µl cDNA, 40
picomoles of forward, and reverse primers. All sequence-specific oligonucleotide primers
(Invitrogen, Carlsbad, CA, USA) are presented in (Table 2). The data reported from q-PCR
is represented in fold expression, calculated as the cycle threshold difference between
control and sample, normalized with the housekeeping genes beta actin and 18s.
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Table 2. Nucleotide sequence. All forward and reverse primers for each examined gene.
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TABLE 2
Gene

Forward Nucleotide Sequence

Reverse Nucleotide Sequence

Myh7

5’- ATCAAATCATCCAAGCCAACCC

5’- GAGGAGTTGTCATTCCGAACTG

Myh4

5’- TTGTGGTGGATGCTAAGGAGTC

5’- GTACTTGGGAGGGTTCATGGAG

CS

5’ - CACTGTTGAGATGGACACACTG

5’ – TCCTGAAGTCTGCATCATGACT

SOD-1

5’- GAACCAGTTGTGTTGTCAGGAC

5’- GCCTTGTGTATTGTCCCCATAC

SOD-2

5’- GGTCACAGTTTCACAGTACACC

5’- TCACAGCCTTGAGTTACAGAGT

TFAM

5’ - GAGAGCTACACTGGGAAACCACA

PGC-1a

5’- CTTTCTGGGTGGATTGAAGTGG

5’- CTCAAATATGTTCGCAGGCTCA

Rn18S

5’- CACGGACAGGATTGACAGATTG

5’- GACAAATCGCTCCACCAACTAA

ß-actin

5’- CCCTGAAGTACCCCATTGAACA

5’- CACACGCAGCTCATTGTAGAAG
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5’ – CATCAAGGACATCTGAGGAAAA

Statistical Analysis. All data were expressed as means ± SE. One-way ANOVA analyses
were conducted on each data set with Tukey’s post-hoc analysis used between groups after
significance was obtained. Significance was determined as a p-value<.05.

Results
Exercise diminishes loss of CSA and weight. Wet muscle weight was measured
immediately after excision. Muscle weights were standardized to bodyweight (mg/g) to
account for individual size variation (Table 3). HLS resulted in a significant decrease
(p=.001) of 27.1% in soleus muscle and a significant decrease (p=.001) of 21.5% in
gastrocnemius muscle weight to bodyweight ratio compared to Control. Exercising prior
to HLS resulted in only a 5.6% non-significant decrease (p=.50) in soleus muscle and an
8.1% non-significant decrease (p=.16) in gastrocnemius weight to bodyweight ratio
(Table 3). Both the soleus and gastrocnemius Ex+HLS group ratios were significantly
greater than the HLS group (p=.001 and p=.007, respectively). Furthermore, crosssectional area (µm2) differences followed a similar trend with HLS resulting in a
significant decrease compared to Control (p<.01), while Ex+HLS and Ex groups were
both significantly greater than HLS (p<.01) (Fig. 6 and 7).

Hindlimb blood flow is not a limiting factor. Laser Doppler imaging of the left hindlimb
assessed blood flow through a prominent posterior limb artery superior to the
gastrocnemius (Fig. 8). This measurement is a function of red blood cell (RBC) content
and the velocity of RBCs through the vessel of interest. Changes in RBC content and
velocity to peripheral tissues could account for variations in the tissue if oxygen and
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Table 3. Bodyweight and muscle weights. Bodyweight (BW) pre-HLS (g) and BW at
time of sacrifice. Muscle weight of both the soleus and gastrocnemius. All data presented
as means ± SE. Statistical significance (p<.05) between groups indicated by the
superscript letter associated with each particular group (a: Control, b: HLS, c: Ex+HLS,
d: Ex).
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TABLE 3
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Figure 6. Soleus CSA. A. Immunofluorescence laminin staining of soleus muscle fibers.
All pictures are 200 µm in width. B. Cross-sectional area (µm2) measurement acquired
using ImageJ software (n=6). Statistical significance (p<.05) indicated by the
corresponding group letter (means ± SE).
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FIGURE 6

B.
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Figure 7. Gastrocnemius CSA. A. Immunofluorescence laminin staining of
gastrocnemius muscle fibers. All pictures are 200 µm in width. B. Cross-sectional area
(µm2) measurement acquired using ImageJ software (n=6). Statistical significance
(p<.05) indicated by the corresponding group letter (means ± SE).
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FIGURE 7

B.
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Figure 8. Hindlimb blood flow. A. Laser Doppler blood flow measurement of
prominent vessel in the dorsal hindlimb. B. Blood flux measurement comparison between
groups (n=6, p<.05). Statistical significance (p<.05) indicated by the corresponding group
letter (means ± SE).
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FIGURE 8

B.
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nutrient delivery along with waste removal are different between groups. Here we show
while Ex tended to increase blood flow in this particular vessel, there were no significant
differences between groups (p=.53).

Exercise increases functional muscle protein. According to Sliding Filament Theory,
skeletal muscle contraction results from the cyclic interaction of actin and myosin
molecules and the recycling of ATP (49). Loss of these protein molecules is an indicator
of muscle atrophy and correlates with decreased fatigue resistance of the muscle (34, 57).
HLS resulted in a no significant change in slow myosin heavy chain (SMHC) protein
expression in the soleus muscle and a significant decrease in the gastrocnemius muscle
(Fig. 9 and 10). However, exercise prior to HLS resulted in a significant increase in
SMHC in the gastrocnemius compared to the HLS group (p<.05). Furthermore, exercise
only significantly increased SMHC compared to controls in soleus (p=.014) and
gastrocnemius (p<.01). Using qPCR, we followed up protein expression of SMHC with
gene expression analysis of a slow myosin heavy chain gene, Myh7. In the soleus, Myh7
approached a significant decrease (p=.056) in HLS compared to Control (.94 vs. 1.1,
respectively). In the gastrocnemius, Myh7 was significantly decreased in both HLS and
Ex+HLS compared to Control and Ex with no difference being observed in the Ex group
transcripts compared to control (Fig. 10).
Moreover, disuse of skeletal muscle and cessation of exercise training is
associated with fiber-type transitioning from a slow, more oxidative muscle to a fast,
more glycolytic muscle fiber-type composition (23). We therefore assessed the transcript
levels of the faster, more glycolytic type IIb myosin heavy chain through qPCR analysis
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Figure 9. Soleus MHC analysis. A. Soleus slow myosin heavy chain protein expression
(n=6). B. Western blot analysis of soleus SMHC. Statistical significance (p<.05) between
groups indicated by the corresponding group letter. C. Myosin heavy chain 7 (slowtwitch muscle) gene expression analysis by qPCR. D. Myosin heavy chain 4 (fast-twitch
muscle) gene expression analysis by qPCR. (groups: n=6, p<.05, means ± SE)
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FIGURE 9
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Figure 10. Gastrocnemius MHC analysis. A. Gastrocnemius slow myosin heavy chain
protein expression. B. Western blot analysis of gastrocnemius SMHC. Statistical
significance (p<.05) between groups indicated by the corresponding group letter. C.
Myosin heavy chain 7 (slow-twitch muscle) gene expression analysis by qPCR. (groups:
n=6, p<.05, means ± SE)
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FIGURE 10
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of the Myh4 gene. As expected, in soleus tissue HLS resulted in a significant increase in
Myh4 mRNA compared to Control (21.34 vs 1.15, p<.01). Although Ex+HLS Myh4
transcript levels were significantly elevated from Control, results indicated less mRNA
expression of Myh4 compared to HLS (p<.01) (Fig. 9).

Mitochondrial markers increase with exercise. Skeletal muscle atrophy is associated with
mitochondrial dysfunction (86, 127). Markers of mitochondrial biogenesis and function
were measured via qPCR and Western Blotting analyses to assess our hypothesis that
exercise increases these markers which are correlated with the protection of muscle
weight and size during HLS. To test this correlation, we assessed the transcript and
protein expression of PGC-1α, TFAM, and CS.
In assessing mitochondrial biogenesis, we measured PGC-1α transcript expression
to be significantly increased after the exercise protocol (Ex) in both soleus (Fig. 11) and
gastrocnemius muscles (Fig. 12) compared to Control (2.3-fold and 1.6-fold,
respectively). PGC-1α mRNA levels were significantly decreased in the gastrocnemius
after HLS. The Ex+HLS group, while lower than Ex, was still significantly greater than
HLS in the gastrocnemius (1.12 vs .87, p=.004). Transcript expression of PGC-1α
between Control, HLS, and Ex+HLS in the soleus were not significantly different.
Protein expression of PGC-1α in the soleus muscle (Fig. 11) was significantly greater in
Ex compared to Control (p<.05) while HLS was significantly reduced (p<.05). Ex+HLS
expression of PGC-1α was significantly greater than HLS alone (p<.05). In
gastrocnemius muscle (Fig. 12), the Ex group revealed a nearly 2-fold increase in protein
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Figure 11. Soleus mitochondrial analysis. A. Soleus protein expression via western blot
of mitochondrial markers (SMHC/PGC-1α and TFAM/CS expression measured on same
blots with same loading control, due to size similarities). B. Western blot analysis of
soleus muscle mitochondrial markers. Statistical significance (p<.05) between groups
indicated by the corresponding group letter. C. Gene expression analysis by qPCR of
mitochondrial markers. (groups: n=6, p<.05, means ± SE)
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Figure 12. Gastrocnemius mitochondrial analysis. A. Gastrocnemius protein
expression via western blot of mitochondrial markers (SMHC/PGC-1α and TFAM/CS
expression measured on same blots with same loading control, due to size similarities). B.
Western blot analysis of soleus muscle mitochondrial markers. Statistical significance
(p<.05) between groups indicated by the corresponding group letter. C. Gene expression
analysis by qPCR of mitochondrial markers. (groups: n=6, p<.05, means ± SE)
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expression (p<.01). Furthermore, in gastrocnemius muscle HLS decreased PGC-1α
compared to Control (p<.01). TFAM transcript expression significantly increased in the
soleus (Fig. 6) and increased in trend in the gastrocnemius muscle (Fig. 7) after the
exercise protocol (Ex) compared to Control (1.74 vs 1.03 [p<.05], 1.47 vs 1.09 [p=.30],
respectively). Soleus muscle TFAM transcript levels were not significantly different
between Control, HLS, and Ex+HLS (1.03 vs .83 vs 1.07, respectively) with Ex+HLS
trending greater than HLS (p=.07). TFAM mRNA expression levels in the gastrocnemius
significantly decreased after HLS (p=.016), with the Ex+HLS group being significantly
greater than HLS (3.16 vs .49, p=.001). Protein expression of TFAM was found to be
elevated in Ex compared to Control in both muscles (p<.05). HLS only resulted in no
significant decrease in TFAM protein expression in the soleus and a significant decrease
in the gastrocnemius (p<.05) (Fig. 6 and 7) compared to Control while TFAM of
Ex+HLS was elevated significantly compared to HLS only in the gastrocnemius (p<.05).
Citrate synthetase is a tricarboxylic acid cycle enzyme catalyzing citrate from
acetyl-CoA and oxaloacetate. It is a commonly used biomarker to assess mitochondrial
function and density in skeletal muscle (151). Analysis of the mRNA expression in the
soleus (Fig. 6) revealed greater CS expression in the HLS group compared to Ex+HLS
(p<.05) with no differences between Control, HLS, and Ex groups. Soleus CS protein
expression (Fig. 7) decreased in the HLS group compared to Controls (p<.05) while
Ex+HLS trended greater than HLS but did not reach significance. Moreover, exercise
increased CS protein in soleus muscle compared to all other groups (p<.05). In the
gastrocnemius muscle (Fig. 7), CS mRNA transcripts were significantly reduced in HLS
compared to control (.58 vs 1.01, p=.0001). Ex+HLS and Ex groups were not
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significantly different compared to control but were both significantly greater than HLS
(p<.05). Furthermore, Ex was significantly greater than HLS (p<.05). Protein expression
of CS (Fig. 7) increased significantly in the Ex group compared to all other groups.
However, there were no significant differences between Control, HLS, and Ex+HLS.

Exercise prior to HLS may reduce ROS. Reactive oxygen species are implicated in the
induction of protein degradation and apoptotic pathways, potentially being an important
contributor to the atrophic muscular condition (22). In order to visualize ROS
accumulation, we used a dihydroethidium staining (DHE), solely as an observational
assessment. DHE staining is commonly used to visualize ROS and in previous research is
viewed as the least problematic and most specific ROS dye, due to its ability to easily
permeate cell membranes and its specificity for superoxide anion (106). Observationally,
there were clear differences between groups (Fig. 13 and 14). HLS, as expected, resulted
in greater levels of ROS in both muscles. Ex+HLS appears to be reduced compared to the
excessive positive staining for superoxide anion in the HLS group.
Superoxide dismutases are the main antioxidant defense system against
superoxide anions (39). Therefore, we measured SOD-1 and SOD-2 (mitochondrial SOD)
transcripts via qPCR and SOD-2 protein expression via Western blot to assess any
differences between groups with these antioxidants. In the soleus we observed a
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Figure 13. Soleus ROS and antioxidants. A. Observational soleus dihydroethidium
staining for ROS. Bright spots are assumed to be positive staining for superoxide anion
(n=6). B. Soleus protein expression via Western blot analysis for antioxidant enzyme
SOD-2. Statistical significance (p<.05) between groups indicated by the corresponding
group letter. C. Soleus SOD-1 and SOD-2 gene expression via qPCR. (groups: n=6,
p<.05, means ± SE)
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Figure 14. Gastrocnemius ROS and antioxidants. A. Observational gastrocnemius
dihydroethidium staining for ROS. Bright spots are assumed to be positive staining for
superoxide anion (n=6). B. Gastrocnemius protein expression via Western blot analysis
for antioxidant enzyme SOD-2. Statistical significance (p<.05) between groups indicated
by the corresponding group letter. C. SOD-1 and SOD-2 gene expression via qPCR.
(groups: n=6, p<.05, means ± SE)
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significant increase in SOD-2 protein expression after exercise (Ex) (P>.01) compared to
all other groups with a trending decrease in SOD-2 expression in HLS. Gastrocnemius
SOD-1 and SOD-2 mRNA expression of the Ex+HLS group was significantly greater
than all other groups (p<.01). SOD-2 protein expression in this muscle was significantly
greater in both Ex and Ex+HLS groups compared to both Control (p<.01) and HLS
(p<.01), respectively.

Discussion
Skeletal muscle atrophy is the result of an imbalance of protein degradation and
protein synthesis. When degradation exceeds synthesis, the result is a loss of muscle
mass. The correlation between skeletal muscle atrophy and reduced mitochondrial
biogenesis and function (114, 116) as well as increased or unbalanced reactive oxygen
species accumulation is well demonstrated in the literature (33, 102). Furthermore, a
wealth of research reveals exercise training increases markers of mitochondrial function
and biogenesis (44, 75, 87). Therefore, the aim of this study is to assess the effects of
preconditioning the muscle tissue with a short-term exercise protocol prior to hindlimb
unloading as a treatment to prevent atrophy. Secondarily, we aim to analyze
mitochondrial molecular mechanisms associated with exercise preconditioning as a
protective therapy.
Initially, Doppler laser technology used on the hindlimbs of all mice groups under
anesthesia assessed blood flow. Differences in oxygen and nutrient delivery as well as
waste removal in the muscle tissue via changes in blood flow could account for
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differences in tissue health. Prior research in this area reveals a disconnect in blood flow
assessment and atrophy. Nevertheless, according to a 2001 review of microvasculature
changes with disuse atrophy by Tyml et al., multiple animal studies reveal no changes in
blood flow in atrophied muscle as well as no differences in mean blood pressure and
vascular resistance (145). Similarly, our measurements reveal no significant differences
between all groups, indicating these tissues changes are not RBC and velocity related.
Here, we did not account for capillarization and global microvasculature of each muscle,
given our laser was solely directed at a more prominent vessel of the gastrocnemius due
to the constraints of this particular technology. This assessment may account for group
differences and is a limitation of the current study warranting future consideration.
In the disuse model of HLS in mice, previous research shows signs of muscle
atrophy that include changes in muscle weight, CSA, and fiber-type transitioning.
Atrophy may occur in as little as 3 days (14), while other studies reveal atrophy occurring
after 7 or more days of disuse (56, 66, 116). In the present study, we similarly observe
muscle atrophy occurring after 7 days of HLS in both the soleus and gastrocnemius
muscles, indicated initially by reductions in the weight and size of the muscle.
Numerous studies have also intervened various treatments to reduce the effects of
atrophy on skeletal muscles including electrical stimulation, nutrition, and exercise intraor post-HLS (1, 46, 56, 104, 136). However, studies specifically measuring the effects of
interventions, specifically exercise training, pre-HLS are scarce. Here we report greater
muscle weight and cross-sectional area along with decreased slow-to-fast fiber-type
transitioning in mice exercising prior to HLS compared to mice undergoing only HLS.
Similar results of muscle weight and size were observed in a 2016 study in which rats
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were treated with 4 months of swimming exercise before having their hindlimbs
immobilized for 5 days in orthosis to induce atrophy (112). Although many differences
exist between these studies, the researchers report exercise training prior to
immobilization preserves soleus muscle mass compared to rats without exercise training.
Fujino et al. measured soleus muscle mass after treating rats with 1 session of
endurance exercise prior to HLS and, while the exercise group trended higher than the
suspension group, no significant differences were determined (37). This group also noted
reductions in MHC I, a slow MHC, after 14 days of HLS while the group exercising
before HLS trended higher but not significantly. However, a single exercise session may
not be enough stress to induce adequate adaptive changes to provide significant
protection of the muscle over an HLS protocol. Furthermore, adapting to exercise
requires time and can be repetitiously surmounted to achieve, incrementally, greater
adaptations. Such is the foundation of progressive exercise training (142). The use of a
single session negates the factor of time to allow incremental increases in adaptation and
potentially greater skeletal muscle protection. However, shorter-term exercise programs
may be more translatable and useful in human adherence. Therefore, we used a
concurrent protocol in this study that combines aerobic and anaerobic adaptive stressors
over a shorter period (18 days) while still allowing enough time for adaptations to
surmount. Our results indicate similar SMHC results as the Fujino et al. study in the
soleus muscle between these groups and we also report a significant increase in
gastrocnemius SMHC in the group exercising before HLS, potentially revealing muscle
group differences in exercise adaptations and HLS effects.
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It is well-established a reduction in markers of mitochondrial biogenesis and
function are correlated with skeletal muscle atrophy (67, 99, 116). Liu et al. observed
diminished mitochondrial respiration prior to activation of protein degradation pathways
in a toxin-induced mouse atrophy model (86) while another group observed markers of
mitochondrial biogenesis increasing prior to the regeneration of muscle after atrophy
(28), indicating potential timelines of effect of mitochondrial function. The present
research similarly revealed significant decreases in PGC-1α in both muscles while
tending to decrease TFAM in the soleus and significantly decreasing TFAM in the
gastrocnemius after HLS. We also observed decreases in trend and with significance of
CS, a commonly used marker of mitochondrial function, across both muscles (81)
establishing evidence for mitochondrial changes being correlated to the atrophy in the
present study.
Based on this evidence, exercise was chosen as a preconditioning treatment to
prevent disuse-associated atrophy because of the well-known inducing effect it has on
mitochondrial biogenesis, particularly PGC-1 α and TFAM, and mitochondrial function
(61, 87, 119). Indeed, our measurements of the Ex group mirrored this previous research,
as we observed increases in gene expression and protein content across both muscles in
many of these markers after the exercise protocol. It may be the increased molecular
mitochondrial adaptations achieved by exercise provides enough lasting, anti-atrophic
benefits over a 7-day HLS protocol to diminish the negative effects on skeletal muscle.
Moreover, muscle protein synthesis is a high-ATP consuming process and studies suggest
a mitochondrial dysfunction role being at the center of diminished muscle protein
synthesis in atrophic conditions due to reduced ATP production (58). Exercise, by itself,
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is also well known to activate protein synthesis pathways (Akt/mTOR) in skeletal muscle
(24). Therefore, by concentrating on treating the mitochondria through exercise we
attempt to shift the balance of degradation and synthesis towards saving muscle tissue.
We also find a wealth of evidence in prior research establishing protein
degradation markers upregulated with muscle disuse (30, 56) and ROS as a prominent
inducer of protein degradation pathways (ubiquitin-proteosome pathway, NF-κB, murf-1,
atrogin-1/MAF-bx), apoptotic pathways, and mitochondrial dysfunction in skeletal
muscle atrophy (22, 64, 97). Experiments quantifying ROS are generally variable,
leading our account for ROS through DHE staining to be strictly observational in
searching for particular trends between groups. Indeed, we observe high expression of
ROS, specifically superoxide anion, in both muscles after HLS while exercising prior to
HLS resulted in lower expression of ROS indicating a potential connection between ROS
and muscle health in the present study. Cannavino et al. reported similar results through
DHE staining, showing significant increases in superoxide anion after a 7-day hindlimb
suspension in mice (14).
The mitochondrial respiratory chain is responsible for ATP production but also
produces superoxide anion under normal physiologic circumstances, mainly from
complex I and complex III (26). It is the excessive and unbalanced accumulation of ROS
that leads to deleterious effects of mitochondrial and cellular proteins associated with
atrophy. SOD-1 and SOD-2 (mtSOD) are antioxidants that neutralize ROS by accepting
the unpaired electron of superoxide anion and converting to hydrogen peroxide, which is
then further converted to water in the presence of glutathione peroxidase. Exercise
acutely increases ROS leading to the transcription of antioxidants that neutralize
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oxidative stress caused by increased respiration and results in an adaptation of increased
levels of SOD over time to neutralize superoxide anions (133). Here, we also observe
increased SOD-2 antioxidant expression in both muscles after the exercise protocol in the
present study. The gastrocnemius revealed elevated levels of SOD-2 after Ex+HLS in
both the mRNA and protein expression and not only after the exercise protocol (Ex) like
that of the soleus. The gastrocnemius may be able to better withstand ROS accumulation
during atrophic settings after exercise training due to a greater and more lengthy SOD-2
response. While the soleus muscle revealed increased SOD-2 after exercise, by the time
the HLS protocol was over levels were not significantly different compared to HLS
indicating potential differences among muscle fiber types. The change in antioxidants
may potentially provide a protective effect against ROS that accumulates during disuse
and further implicates exercise as an effective preconditioning treatment.

Conclusions. Skeletal muscle atrophy is correlated with reduced mitochondrial biogenesis
and function along with excessive ROS leading to the activation of protein degradation
and apoptotic pathways as well as reductions in protein synthesis. Here we show exercise
training prior to an atrophic setting protects skeletal muscle from HLS-induced atrophy
by inducing the potentially protective molecular effects of increased markers of
mitochondrial biogenesis and function with increased antioxidant status. Exercise training
prior to an atrophic setting may be a useful intervention to alleviate skeletal muscle
atrophy caused by disuse and unloading. Furthermore, mitochondrial directed treatments
could be a useful area of study in the prevention of muscle atrophy.
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CHAPTER III

TFAM OVEREXPRESSION DIMINISHES SKELETAL MUSCLE ATROPHY

Introduction
Skeletal muscle functions not only in propulsion for locomotion but also as a
glucose and amino acid reservoir (117). It is the largest organ in the body and functions
as an endocrine secretory tissue (109). Notably, skeletal muscle strength is a key
predictor of life span (92) and vitality. Being that this muscle functions in a variety of
important processes, pathological losses can greatly affect health and quality of life.
Skeletal muscle atrophy is the loss of muscle tissue and is characterized by a
decline in muscle mass leading to reductions in force production, decreased crosssectional area of the muscle fibers, and diminished oxidative ability (140). As this tissue
atrophies, the ability to perform physical tasks is greatly reduced and can significantly
decrease the physical independence of the patient as well as increase factors of morbidity
and mortality (113). Furthermore, when patients enter a scenario in which atrophy occurs,
resources must be devoted to the mitigation and recovery process, such as
pharmacological interventions or the use of rehab specialists. Therefore, preventing the
condition of skeletal muscle atrophy is an important research endeavor to improve the
patient condition, both physically and fiscally.
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While many scenarios may cause skeletal muscle atrophy (disease, starvation, and
aging), the mechanical unloading and disuse of muscle results in specific atrophic
changes. Skeletal muscle is abnormally disused or unloaded during circumstances such as
bedrest, limb immobilization, spinal cord injury, microgravity, and a sedentary lifestyle
(162). During all of these scenarios, significant reductions in fiber contraction and
mechanical stress on the muscle tissue occur, leading to potentially abrupt and reductive
structural and molecular changes (55).
Disuse-induced atrophy results in the loss of muscle fiber size, weight, and
function (16). When this occurs, decreases in molecular signaling pathways leading to
protein synthesis and increases in molecular pathways leading to protein degradation and
apoptosis are observed, resulting in a net loss of muscle protein (55, 141). These
molecular mechanisms are also correlated with mitochondrial dysfunction and redox
imbalance (102, 127). Dysfunctional mitochondria and excessive reactive oxygen species
(ROS) accumulating during muscle atrophy reduces protein synthesis and activates
protein catabolic mechanisms (22, 64, 97). ROS, in particular, can accumulate in the
mitochondria and damage mtDNA, leading directly to dysfunction through the mutation
of mtDNA and the transcription and translation of dysfunctional mitochondrial proteins
(156).
Exercise powerfully stimulates mitochondrial function through small molecular
changes that occur with physical activity and converge on the upregulation of the masterregulator protein, peroxisome proliferator-activated receptor gamma coactivator 1-alpha
(PGC-1α) (118). This master regulator co-activates with nuclear-respiratory factors 1 and
2, increasing the transcription of mitochondrial transcription factor A (TFAM).
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Translated TFAM is translocated into the inner-mitochondrial matrix and re-folded into
its mature form where it can interact with mtDNA leading to increased mtDNA
transcription. TFAM also abundantly binds mtDNA forming histone-like nucleoid
structures to store, maintain, and protect mtDNA from binding and degradation via ROS
(79).
Substantial evidence in prior research implicates the strong link of TFAM and
mitochondrial health. Reviewing animal studies of TFAM, we see a germ line disruption
of the mouse TFAM (TFAM -/-) gene leading to extreme reductions in mtDNA and
embryonic lethality (111). A 2004 study using a combination of TFAM overexpression
and knockout mice reveals mtDNA copy numbers are directly proportional to TFAM
levels (31). Balliet et al. showed a lack of TFAM resulted in mitochondrial dysfunction
due to the loss of OXPHOS proteins (148). In contrast, an in vivo treatment with a
recombinant form of TFAM resulted in increased motor endurance and complex-I
respiration in mice (54).
There is evidence in a limited number of in vivo and in vitro TFAM
overexpression studies that reveal decreased left-ventricular remodeling after myocardial
infarction and an overall protective role of TFAM in cardiomyocytes (38, 52),
establishing the important role of TFAM in a muscle tissue. In skeletal muscle, a mouse
model with a skeletal-muscle specific disruption of TFAM led to mitochondrial
myopathy, ragged-red fibers, reduced muscle force, abnormal mitochondrial shape, and
decreased respiratory chain activity (157) specifically indicating its vital role in skeletal
muscle. During skeletal muscle differentiation, increases in TFAM mRNA levels
corresponded with increases in mitochondrial content and the authors concluded TFAM
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protein levels are regulated by the availability of TFAM mRNA (18). Furthermore, we
see overexpressing PGC-1α in a mouse model prevents disuse-induced skeletal muscle
atrophy of the soleus (14). With TFAM being transcribed downstream of PGC-1α and
tightly associated with mitochondrial function, a TFAM mechanism of skeletal muscle
protection may exist. There are no known studies, to the best of our knowledge,
analyzing TFAM overexpression in a mouse disuse-induced skeletal muscle atrophy
model.
Therefore, we hypothesize overexpressing TFAM in mouse skeletal muscle will
prevent or diminish unloading and disuse-induced atrophy. To test this, we use a 7-day
hindlimb suspension (HLS) protocol to induce muscle atrophy in the hindlimbs of mice
to be compared with wild-type mice entering the same HLS protocol. While we have
separately shown exercise prior to HLS diminishes atrophy in wild-type mice (article in
submission), here we further aim to observe if exercising TFAM overexpression
transgenic mice prior to HLS results in a combination treatment effect to prevent muscle
atrophy. Our results indicate overexpressing TFAM results in significantly diminished
soleus and gastrocnemius atrophy prompting potential future research in genetic and
molecularly directed therapies.

Methods
Animal and ethical approval. Male C57BL/6J mice (WT) and male C57-based transgenic
mice overexpressing the TFAM gene (Cyagen Bioscience, Inc.) were used for analysis.
Genotyping confirmed the positive transgene in each mouse used in the present study.
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The TFAM transgenic groups consisted of a control (T-Control), hindlimb suspension (THLS), and exercise prior to hindlimb suspension (T-Ex+HLS). Four groups of wild-type
mice (WT) were used as comparison to transgenic groups including a Control, hindlimb
suspension (HLS), exercise before hindlimb suspension (Ex+HLS), and exercise only
(Ex) group. All data from WT mice are derived from our recent work and are being
submitted in combination with the present study for publication. WT data will be used
solely as comparative data for the objectives of this study. Mice that exercised prior to
suspension were placed in HLS the same day after their last exercise session and all mice
were sacrificed immediately after HLS. All mice were 13±1 weeks of age at the time of
sacrifice. Wild-type mice were purchased from Jackson Laboratory (Bar Harbor, ME)
and transgenic mice were purchased from Cyagen Biosciences, Inc. (Santa Clara, CA).
All standard procedures and experiments involving animals were approved by the
Institutional Animal Care and Use Committee of the University of Louisville and
conformed with the National Institutes of Health guidelines.

Hindlimb suspension. Custom built cages were used to unload the hindlimb musculature
and induce atrophy for 7 continuous days. Cage construction followed similar guidelines
as previously shown (36). Briefly, mice were first placed under continuous isoflurane
anesthesia while a tail harness was attached. The tail was cleaned then taped crosssectionally. A 27-gauge needle cap was cut down to ~2 centimeters in length with
openings on each end. A small hole was created in the sidewall of the needle cap and a
nylon string was used to tie a loop through this hole. This cap was placed over the tail
and taped into place roughly 1/3 of the tail length from the base. The nylon loop and cap,
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now taped to the tail, could then be attached to the roof of the cage, suspending the
animal’s hindlimbs. This also allowed the forelimbs to bear weight and the animal to
move around the cage. Mice could also access food and water ad libitum in this manner.
Bodyweights were recorded before and after suspension.

Exercise Protocol. Exercise consisted of 14 training sessions over 18 days of treadmill
running in a concurrent style of exercise (combining more than one mode of exercise).
An acclimation period to treadmill exercise occurred during the first four sessions. The
following 10 sessions consisted of 6 endurance training style exercise sessions and 4
high-intensity interval style exercise sessions. All exercise program details (Table 4) were
matched between exercising groups.

Laser Doppler. Laser Doppler imaging (Moor FLPI, Wilmington, DE) of lower, hindlimb
blood flow was done for each group and used to assess flux of the hindlimb after
treatments. Mice were first administered anesthesia (tribromoethanol) standardized to
bodyweight. The musculature of the left, lower hindlimb was then exposed, revealing the
musculature of the leg. Each mouse was placed in a prone position and the laser height
was positioned roughly 15 cm from a prominent vessel superficial to the gastrocnemius.
Flux measurements were recorded for 2 mins and quantified.
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Table 4. Exercise protocol. Mouse concurrent treadmill exercise protocol consisting of a
“Week 1” acclimation, followed by progressive training “Week 2” and “Week 3”. Three
days per week (M,W,F) consisted of endurance-style exercise while two days per week
(T,TH) consisted of higher-intensity interval sprint style of exercise.
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TABLE 4
WEEK 1
Warmup
Work Rate
Rest
Distance

Monday
OFF

Tuesday
7m/min. for 50m
7m/min.
3min. off/100m
300m

Wednesday
7m/min. for 50m
8m/min.
3min. off/100m
300m

Thursday
7m/min. for 50m
9m/min
3min. off/100m
300m

Friday
7m/min. for 50m
10m/min.
3min. off/100m
300m

WEEK 2
Warmup
Work Rate
Walk Rate
# of Sprints
Rest
Distance

Monday
7m/min. for 50m
11m/min.
3min. off/100m
350m

Tuesday-Sprints
7m/min. for 50m
15m/min. for 10m
7m/min. for 10m
8
5mins after 5 sprints
160m

Wednesday
7m/min. for 50m
12m/min.
3min. off/100m
375m

Thursday-Sprints
7m/min. for 50m
17m/min for 15m
7m/min. for 15m
10
5mins after 5 sprints
300m

Friday
7m/min. for 50m
13m/min.
3min. off/100m
400m

WEEK 3
Warmup
Work Rate
Walk Rate
# of Sprints
Rest
Distance

Monday
7m/min. for 50m
13.5m/min.
3min. off/100m
450m

Tuesday-Sprints
7m/min. for 50m
18m/min. for 15m
7m/min. for 15m
11
5mins after 5 sprints
330m

Wednesday
7m/min. for 50m
14m/min.
3min. off/100m
500m

Thursday-Sprints
7m/min. for 50m
20m/min. for 20m
5x-7m/20m; 6x-7m/10m
11
5mins after 5 sprints
380m

Friday
7m/min. for 50m
14.5m/min.
3min. off/100m
550m
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Tissue extraction and weight. Both the soleus and gastrocnemius tissues were excised and
separated from each leg for all experimental groups. Each muscle was washed with 50
mmol/L phosphate buffer saline (PBS) pH of 7.4, weighed individually, snap frozen in
liquid nitrogen, and stored at −80°C until use. All tissue extraction methods and timings
were equated across all groups.

Immunofluorescence . One of each muscle was cut cross-sectionally at the muscle midbelly
and placed in tissue-freezing medium (Triangle Biomedical Sciences, Durham, NC, USA)
in disposable plastic tissue-embedding molds (Polysciences Inc., Warrington, PA, USA).
These tissue blocks were immediately frozen and stored at -80°C until use. Cryosections
of each muscle, 7-10 µm thick, were obtained using a Cryocut System (CM 1850; Leica
Microsystems, Buffalo Grove, IL, USA). These tissue sections were placed on Poly-LLysine coated microscope slides (Polysciences, Inc., Warrington, PA, USA) prior to use.
Slides containing tissue sections were fixated in acetone for 20 mins, washed in 1X PBST solution, and incubated with a permeabilization solution (0.2 g Bovine Serum Albumin,
3 ul Triton X-100 in 10ml 1X PBS) for 1 hour at RT. This was followed by multiple
washing steps with 1X PBS-T. The sections were incubated with a primary antibody (antiLaminin; Abcam, Cambridge, MA, USA) solution with a dilution of 1:200 overnight at
4°C. After multiple washing steps with 1X PBS-T, the slides were incubated with a
fluorescently labeled secondary antibody (goat anti-mouse Alexa flour 594; Invitrogen,
Waltham, MA, USA) with a 1:300 dilution for 1 hour at RT. This was followed by another
washing step, then slides were mounted with mounting medium and glass cover slips
placed over the sections and air dried overnight in dark container. These samples could
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then be visualized using a laser scanning confocal microscope (Olympus Fluo View 1000;
Center Valley, PA, USA). Cross-sectional area (CSA) measurements were acquired using
these laminin images by hand tracing single, stained muscle fibers in ImageJ software.

DHE staining for ROS. After tissue excision, each muscle was cross sectioned in half,
immediately placed in tissue-freezing medium (Triangle Biomedical Sciences, Durham,
NC, USA), snap frozen and stored at -80°C until use. Samples were sectioned on a cryostat,
placed on slides, and in situ superoxide generation was evaluated in each cryosection with
the oxidative fluorescent dye dihydroethidium (DHE). Cryosections (10 μm) were
incubated with DHE (2 μmol/l) in a PBS solution. After multiple washing steps, slides were
mounted with mounting medium and a cover slip and allowed to dry. These samples were
then visualized using a laser scanning confocal microscope (Olympus Fluo View 1000;
Center Valley, PA, USA).

Protein Extraction and Protein Estimation. Both muscle tissue samples from all groups
were bead-homogenized in ice‐cold RIPA (1 mmol/L) buffer with PMSF and protease
inhibitor cocktails (1 μL/mL of lysis buffer, Sigma Aldrich, St. Louis, MO). Centrifugation
followed with these samples at 12,000 g for 20 min at 4°C. All supernatant was extracted,
placed in Eppendorf tubes, and immediately stored at −80°C until use. Protein estimation
of each sample was measured by the Bradford‐dye (Bio‐Rad, CA) method in a 96‐well
microliter plate compared against a Bovine Serum Albumin (BSA) standards. This plate
was analyzed at 594 nm in a Spectra Max M2 plate reader (Molecular Devices Corporation,
Sunnyvale, CA).
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Western Blot Analysis. Protein lysates (40 µg) were prepared and heated at 95°C for 5 min.
These samples were then loaded into an SDS polyacrylamide gel submerged in running
buffer and run at a constant current (75 Volts). Proteins were then transferred to a PVDF
membrane overnight at 120 mA at 4°C. After the transfer, membranes were blocked in 5%
nonfat milk for 1 hour at room temperature and then incubated overnight with the primary
antibody (Anti-SOD2; GAPDH; Abcam, Cambridge, MA, USA.) at 4°C with slow
agitation. Washing steps occurred the next day with a TBS-T buffer, then membranes were
incubated with secondary antibody (horse radish peroxidase-conjugated goat anti-rabbit
IgG, goat anti-mouse; Santa Cruz Biotechnology, Dallas, TX, USA) for 1 hour at RT with
a 1:5000 dilution followed by another washing step. The membranes were developed using
an ECL Western blotting detection system (GE Healthcare, Piscataway, NJ, USA) and all
images were recorded in the gel documentation system ChemiDoc XRS (Bio-Rad,
Richmond, CA, USA). Membranes, if being re-used, were stripped with stripping buffer
(Boston BioProducts, Ashland, MA, USA) and blocked with 5% milk for 1 hour at RT
under agitation. After washing, membranes were incubated with the anti-Gapdh antibody
(Millipore, Billerica, MA, USA) as a loading control protein. The data were analyzed by
Bio-Rad Image Lab densitometry software and normalized against anti-Gapdh bands.

Quantitative PCR. In the assessment of mRNA transcripts of specific genes in skeletal
muscle, RNA was isolated with TRIzol® reagent (Life Technologies, Carlsbad, CA, USA)
according to the instructions of the manufacturer. The RNA quantification and purity was
assessed by nanodrop-1000 (Thermo Scientific, Walthan, MA, USA). Aliquots (2μg) of
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total RNA were reverse-transcribed into cDNA using a High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Foster City, CA) according to the protocol of the
manufacturer. Quantitative PCR (q-PCR) was performed for different genes (TFAM,
Myh4, SOD-1, SOD-2), in a final reaction volume of 20 µl containing 10 µl PerfeCTa
SYBR Green SuperMix, Low ROX (Quanta Biosciences, Gaithersburg, MD), 6 µl
nuclease free water, 2µl cDNA, 40 picomoles of forward, and reverse primers. The
information in Table 5 presents all sequence-specific oligonucleotide primers (Invitrogen,
Carlsbad, CA, USA). The data was represented in fold expression. This was calculated as
the cycle threshold difference between control and sample normalized with the
housekeeping genes beta actin and 18s.

Stastical Analysis. All data were expressed as means ± SE. One-way ANOVA analyses
were conducted on each data set with Tukey’s post-hoc analysis used between groups
within the same mouse line and the student t-test used between mouse line groups of
relevance. Significance was determined as a p-value<.05.

Results
TFAM overexpression reduces atrophic changes. Wet muscle weights were recorded
immediately after tissue excision. A muscle weight to bodyweight (mg/g) standardization
ratio was used to account for individual size variation. HLS resulted in non-significant
decreases of 8.3% in soleus (Fig. 15) and 2.6% in gastrocnemius (Fig. 16) muscle weight
to bodyweight ratio in mice overexpressing TFAM (T-HLS), compared to TFAM
Control. Our conjoined work revealed a 27.1% decrease in wild-type soleus and a 21.5%
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Table 5. Nucleotide sequence - TFAM. All forward and reverse primers for each
examined gene.
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TABLE 5
Gene

Forward Nucleotide Sequence

Reverse Nucleotide Sequence

Myh4

5’- TTGTGGTGGATGCTAAGGAGTC

5’- GTACTTGGGAGGGTTCATGGAG

SOD-1

5’- GAACCAGTTGTGTTGTCAGGAC

5’- GCCTTGTGTATTGTCCCCATAC

SOD-2

5’- GGTCACAGTTTCACAGTACACC

5’- TCACAGCCTTGAGTTACAGAGT

TFAM

5’ - GAGAGCTACACTGGGAAACCACA

5’ – CATCAAGGACATCTGAGGAAAA

Rn18S

5’- CACGGACAGGATTGACAGATTG

5’- GACAAATCGCTCCACCAACTAA

ß-actin

5’- CCCTGAAGTACCCCATTGAACA

5’- CACACGCAGCTCATTGTAGAAG
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Figure 15. Soleus weight and CSA. A. Soleus muscle weight to bodyweight ratio (mg/g)
of wild-type and TFAM transgenic groups (n=6). B. Immunofluorescence images of antilaminin staining to visualize muscle fiber size and shape. All pictures are 200 µm in
width. C. Mean cross-sectional area measurement comparison between groups of antilaminin staining images calculated using ImageJ software (n=6). D. Myosin Heavy chain
4 (Myh4) gene expression analysis of the soleus muscle (n=6). Statistical significance
(p<.05) indicated by the corresponding group letter (means ± SE).
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Figure 16. Gastrocnemius weight and CSA. A. Gastrocnemius muscle weight to
bodyweight ratio (mg/g) of wild-type and TFAM transgenic groups (n=6). B.
Immunofluorescence images of laminin staining to visualize muscle fiber size and shape.
All pictures are 200 µm in width. C. Mean cross-sectional area measurement comparison
between groups of anti-laminin staining images calculated using ImageJ software (n=6).
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decrease in wild-type gastrocnemius in this ratio after HLS, compared to wild-type
Control TFAM Ex+HLS led to a non-significant increase of 4.5% in the soleus and
decrease of 0.7% in this ratio in T-HLS, compared to TFAM Control (Fig. 15 and 16).
Cross-sectional area measurements follow a similar, minor trend with T-HLS tending to
decrease in both muscles, although with no statistical significance between these groups,
with T-HLS being significantly greater (Fig. 15 and 16) than wild-type HLS in both
soleus [805um vs. 668um, p<.01] and gastrocnemius [2085um vs. 1605um, p<.01].
Moreover, fiber-type transitioning of the soleus muscle was measured through the qPCR
measurement of Myh4. Here, we see similar levels of Myh4 in both wild-type Ex+HLS
groups compared to T-Ex+HLS while T-HLS resulted in significantly lower levels of
Myh4 compared to wild-type HLS (12.89 vs. 7.75, p<.01).

Greater TFAM expression in gastrocnemius. To assess genetic expression of the TFAM
transgenic model, we completed qPCR analysis of the TFAM transcript across both
muscles (Fig. 17). Soleus TFAM expression in T-HLS mice was greater than wild-type
HLS (1.75 vs. .82, p<.01) while T-Control was greater than wild-type Control (2.35 vs.
1.02, p<.01). In the gastrocnemius, T-HLS was significantly greater than wild-type HLS
(4.23 vs. .49, p<.01) and T-Control was ~5-fold greater than wild-type Control (5.11 vs.
1.09, p<.01).
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Figure 17. TFAM gene expression. A. Soleus TFAM gene expression (n=6). B.
Gastrocnemius TFAM gene expression. Statistical significance (p<.05) indicated by the
corresponding group letter (means ± SE).
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Hindlimb bloodflow does not change. Laser Doppler imaging of the left hindlimb
assessed blood flow through a prominent posterior limb artery superior to the
gastrocnemius (Fig. 18). Flux is a function of red blood cell (RBC) content and its
velocity through the vessel of interest. Lack of RBC content to peripheral tissues may
account for skeletal muscle changes if oxygen and nutrient delivery as well as waste
removal are impaired. Here we show there were no significant differences in flux
between all groups (p=.53).

TFAM overexpression increases SOD-1 and SOD-2. Skeletal muscle degradation and
apoptotic pathways are induced by reactive oxygen species (22, 97). We assessed the
accumulation of superoxide anion, observationally, through the use of DHE staining. In
all TFAM transgenic groups, we consistently observed low positive staining markers
after DHE staining across all groups (Fig. 19). In both soleus and gastrocnemius muscles,
T-Ex+HLS resulted in minimal positive markers while, interestingly, T-Control and THLS appeared to have dull to low positive staining across multiple observations.
Superoxide dismutases (SODs) are antioxidant enzymes that catalyze the
conversion of superoxide anions to hydrogen peroxide (39). Therefore, we measured
SOD-1 (cytosolic) and SOD-2 (mitochondrial) transcripts via qPCR and SOD-2 protein
expression via Western blot to assess inter-group antioxidant differences. SOD-1 mRNA
analysis in the soleus (Fig. 20) revealed significantly greater expression of this gene in T-
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Figure 18. Hindlimb blood flow. A. Laser Doppler blood flow measurement of a
prominent vessel in the dorsal hindlimb. B. Blood flux measurement comparison between
groups (n=6).
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FIGURE 18
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Figure 19. Soleus and gastrocnemius ROS. A. Observational soleus dihydroethidium
staining for ROS. Bright spots are assumed to be positive staining for ROS (n=6). B.
Observational gastrocnemius dihydroethidium staining for ROS. Bright spots are
assumed to be positive staining for superoxide anion (n=6).
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FIGURE 19
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Figure 20. Soleus antioxidants. A. Soleus SOD-1 transcript expression (n=6). B. Soleus
protein expression via Western blot analysis for antioxidant enzyme SOD-2 (n=6). C.
Soleus SOD-2 gene transcript expression. Statistical significance (p<.05) indicated by the
corresponding group letter (means ± SE).
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HLS mice compared to wild-type HLS (P<.05). In the gastrocnemius (Fig. 21), T-Control
and T-HLS SOD-1 transcripts were both roughly 10-fold greater than wild-type Control
and HLS (p<.01).
Transcript analysis of SOD-2 in the soleus (Fig. 20) reveals T-Control being
~4.5x greater than wild-type Control (p<.01). SOD-2 soleus protein expression was
greater in T-HLS compared to wild-type HLS (p<.01) as well as T-Control compared to
wild-type Control (p<.01). After observing gastrocnemius SOD-2 gene expression (Fig.
21), we see the T-Control group with a nearly 5.5-fold increase compared to Control
(p<.01) and T-HLS nearly 6-fold greater than HLS (p<.01). Protein expression of this
antioxidant in the gastrocnemius (Fig. 21) similarly shows increases in both T-HLS and
T-Control compared to HLS and Control, respectively.

Discussion
Atrophy of skeletal muscle arises when protein degradation and apoptosis exceeds
protein synthesis and can occur when the musculature is unloaded or disused (140).
Previously we have shown evidence of atrophy in both the soleus and gastrocnemius
skeletal muscle of wild-type mice following a hindlimb-unloading protocol (article in
submission). This skeletal muscle atrophy is associated with diminished markers of
mitochondrial biogenesis and function, a reduced antioxidant state, as well as a
potentially increased ROS status leading to redox imbalance.
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Figure 21. Gastrocnemius antioxidants. A. Gastrocnemius SOD-1 transcript expression
(n=6). B. Gastrocnemius protein expression via Western blot analysis for antioxidant
enzyme SOD-2 (n=6). C. Gastrocnemius SOD-2 gene transcript expression (n=6).
Statistical significance (p<.05) indicated by the corresponding group letter (means ± SE).
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We successfully reduced atrophy by exercising the musculature prior to hindlimb
suspension (Table 6), which was associated with improvements in many of these
mitochondrial and redox markers. Specifically, we observed a trending decrease in
TFAM gene and protein expression in the soleus and a greater, significant decrease in
TFAM gene and protein expression in the gastrocnemius muscle after HLS. Therefore, in
the present study we attempt to more specifically analyze the role of TFAM in muscle
atrophy using a C57BL/6J-based TFAM overexpression transgenic mouse model in HLS,
while also observing the effects of combining exercise with this transgenic model.
Previous research using TFAM transgenic animal models is scarce. A 2005 study
reported the use of a TFAM transgenic mouse model in a myocardial infarction study and
results indicate TFAM overexpression ameliorated left-ventricular remodeling, providing
a cardiomyocyte protective effect (52). Other in vitro studies similarly reveal a
cardiomyocyte protective role via TFAM overexpression (38, 51). Moreover,
mitochondrial dysfunction in skeletal muscle atrophy is highly associated with excessive
ROS. With TFAM protecting mtDNA from ROS as well as increasing mtDNA
transcription, mtDNA copy number, and mitochondrial biogenesis, we chose to further
investigate its role in skeletal muscle.
Initially, we assessed hindlimb blood flow via Doppler laser technology in a
prominent vessel superior of the gastrocnemius. Blood flow could be a limiting factor in
muscle atrophy due to decreases in the delivery of oxygen and nutrients and the ability to
remove waste. There are discrepancies in the literature concerning muscle atrophy related
blood flow changes. One would assume to see reductions in blood flow after HLS.
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Table 6. Bodyweight and muscle weights. Bodyweight (BW) pre-HLS (g) and BW at
time of sacrifice. Muscle weight of both the soleus and gastrocnemius. All data presented
as means ± SE. Statistical significance (p<.05) between groups indicated by the
superscript letter associated with each particular group (a: Control, b: HLS, c: Ex+HLS,
d: Ex).
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TABLE 6
Group

Control
HLS
Ex+HLS
Ex
T-Ex+HLS
T-HLS
T-Control

Pre-HLS
BW
(g)
23.3 ± .87
24.3 ± .78
23.8 ± .47
26.1 ± .63
-

BW
(g)

Sol MW
(mg)

Gas MW
(mg)

24.5 ± .55
22.0 ± .79
22.4 ± .67
23.5 ± .22
22.9 ± .55
23.8 ± .59
26.9 ± .27

7.8 ± .17
5.1 ± .15a,c,d
6.9 ± .33a,b,d
7.9 ± .12
6.8 ± .44
6.3 ± .27b,g
7.7 ± .32f

121.1 ± 6.10
85.4 ± 5.5a,d
103.8 ± 4.31
110.7 ± 4.30
105.2 ± 1.77
105.9 ± 2.60b
124.5 ± 3.42
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Sol
MW/BW
(mg/g)
.32 ± .01
.23 ± .01a,c,f
.30 ± .01d
.34 ± .003
.30 ± .03
.261 ± .01b
.29 ± .01a

Gas
MW/BW
(mg/g)
4.9 ± .16
3.9 ± .24a,c,f
4.5 ± .07
4.7 ± .15
4.59 ± .14
4.5 ± .12 b
4.63 ± .09

However, according to Tyml et al. in a 2001 review of the microvasculature changes in
disused muscle, this assumption may be incorrect. Multiple animal studies reported here
on muscle disuse reveal no changes in blood flow in atrophied muscles, indicating no
changes in mean blood pressure and vascular resistance (145). We similarly observe
these effects in blood flow with no differences between groups. However, this assessment
does not specifically analyze capillarization or microvasculature of each muscle, which
may reveal differences. This limitation in conjunction with the current findings warrants
future investigation.
After HLS in transgenic mice we observe muscle wet weight, muscle
weight/bodyweight ratio, and cross-sectional area are all significantly greater in both the
soleus and gastrocnemius of the T-HLS group compared to the wild-type HLS group,
indicating an initial, potential protective role of TFAM overexpression (Fig. 22, Table 6).
TFAM abundantly binds and protects mtDNA from mitochondrial ROS. As greater
TFAM comes in contact with mtDNA, greater protection is expected (78). TFAM
expression is also positively correlated with mtDNA copy number (31). Therefore, results
from the current study suggest supra-physiologic gene expression of TFAM may lead to,
speculatively, increased mtDNA protection during an atrophic setting with increased
ROS, preserving muscle tissue from atrophy via mitochondrial protection.
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Figure 22. Exposed lower hindlimb. Dorsal view of the exposed lower left hindlimb
with mice, under anesthesia, placed in a prone position. Observational differences
between groups.
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FIGURE 22
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In the present study, the transgenic gastrocnemius muscle appears to have a more
pronounced protective effect from atrophy with minimal reductions in muscle weight,
size, and shape compared to the greater changes observed in the transgenic soleus. Our
recent research indicates mitochondrial biogenesis markers, particularly TFAM gene and
protein expression, in the wild-type gastrocnemius is more affected by 7 days of HLS
(article in submission). Yajid et al. also report muscle group mitochondrial differences
where they conclude mitochondrial respiration is most affected in the gastrocnemius after
HLS in rats. Here the researchers analyzed mitochondrial respiration in 4 separate
muscles, including the soleus, and noted a 59% decrease in gastrocnemius state 3
respiration with disuse atrophy (158). The implication is muscle groups with very
different fiber-type makeups may respond to atrophy differently, and thus should be
analyzed separately when creating therapeutics.
Nonetheless, while it appears the gastrocnemius may be more susceptible to
mitochondrial changes during disuse and potentially able to respond better to
mitochondrial treatment via the overexpression of the TFAM gene, we must also
emphasize muscle fiber-type differences between muscle groups. In the analysis of
C57BL/6J mouse muscle fiber-type composition, the soleus muscle reportedly consists of
much higher oxidative fibers with 37% type-I fibers and 38% type-IIA fibers while the
gastrocnemius consisted of much lower oxidative fibers with only ~6% type-I and ~6%
type-IIA but over 54% type-IIB fibers (2). Oxidative fibers tend to have greater
mitochondrial content and density while fast-glycolytic fibers tend to have less
mitochondrial content (88). In speculation, due to the lower volume of mitochondria in
the gastrocnemius, there may be a greater sensitivity to even minor mitochondrial
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changes, such as the decreases in TFAM we observe in HLS. By overexpressing this
highly important gene in mitochondrial health and function that directly protects mtDNA
copy number and activates mtDNA transcription, it may blunt the gastrocnemius
sensitivity to mitochondrial fluctuations. While the gastrocnemius in wild-type mice
revealed a significant decline in TFAM gene and protein expression after HLS, there was
no significant difference in soleus TFAM gene and protein expression in wild-type mice
after HLS. The soleus, with greater mitochondrial densities and no significant decreases
in TFAM, did not benefit from increased TFAM transcript expression to the same extent
while the gastrocnemius, with significant declines in TFAM after HLS, had the
physiologic capacity to benefit from overexpression.
We also observed differences in expression levels between muscles in the
transgenic mice. To investigate this further, measurements of TFAM mRNA expression
in transgenic mice against wild-type mice revealed a nearly 2.5-fold increase in
transgenic soleus TFAM mRNA compared to ~5-fold increase in transgenic
gastrocnemius TFAM mRNA (Fig. 17). This difference was similar across all transgenic
treatment groups indicating a potential difference in fiber-type response to the random
integration of the TFAM transgenic construct. Interestingly, in a study using a PGC-1α
overexpression mouse model, the authors note the potential for certain promoters to be
more highly expressed in fast-fibers compared to slow-fibers (14). Although purely
speculation, this may play a role in the current study to account for expression differences
between muscle types.
We previously observed increased superoxide anion after HLS in wild-type mice,
which was similar to DHE staining results in skeletal muscle after 7-day HLS by
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Cannavino et al. (14). In the present study, we observe much lower expression of ROS
across both muscles of all transgenic groups compared to wild-type. Also, we see
increases in SOD-1 gene expression and SOD-2 protein expression of both muscles, with
the transgenic gastrocnemius revealing more pronounced levels of gene expression of
both antioxidants compared to the transgenic soleus. These findings are unexpected and
links TFAM gene overexpression with increased antioxidant status. Interestingly, a 2009
study isolating mtDNA nucleoids revealed the presence of SOD-2 within each nucleoid,
potentially acting as a front-line antioxidant defense barrier for mtDNA (72).
Speculatively, it is possible overexpressing TFAM results in increased mtDNA binding
and greater nucleoid formation, leading to a higher presence of SOD-2 expression
antioxidant defense overall. The exact mechanism between these two molecules appears
to be unknown, to our knowledge, and worthy of future investigation.

Conclusion. Skeletal muscle atrophy is highly correlated with reduced mitochondrial
biogenesis and function along with excessive ROS leading to the activation of protein
degradation and apoptotic pathways and the reduction in protein synthesis. Here we
follow up on our recent research that correlated diminished mitochondrial markers with
skeletal muscle atrophy and attempt to display a protective role of TFAM in disuseinduced skeletal muscle atrophy. Moreover, there may be a more pronounced effect in the
gastrocnemius muscle to TFAM overexpression, which should be considered in future
research. Our results indicate the overexpression of the TFAM gene is associated with
increased antioxidant expression as a possible mechanism to prevent catabolic pathway
induction in skeletal muscle disuse. TFAM directed pharmaceuticals or therapies to
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manipulate this molecule is an attractive area of research in preventing skeletal muscle
atrophy. Future research into this molecule could also focus on other tissues and
pathologic areas in which mitochondrial biogenesis and dysfunction plays a major role.
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CHAPTER IV
CONCLUDING DISCUSSION

The studies presented in this project were meant to further our knowledge of the
effect of exercise on skeletal muscle and to attempt to prevent the unwanted effects of
atrophy during disuse. We reasoned since reductions in markers of mitochondrial
biogenesis and function as well as redox imbalances were highly correlated with skeletal
muscle atrophy in numerous research studies, observing and treating this mechanism to
prevent atrophy may be a useful research endeavor. First, we hypothesized that exercise
training prior to a disuse-induced atrophic setting would prevent skeletal muscle atrophy.
Second, we hypothesized that this prevention of atrophy would be associated with
changes in mitochondrial markers.
To test our initial hypothesis, we first needed to determine if a 7-day hindlimb
suspension protocol would induce atrophy and if exercise training prior to this atrophic
event was linked to atrophy prevention. To test our secondary hypothesis, we had to
assess the molecular changes associated with this treatment. As discussed in Chapter II,
HLS results in a 27.1% and 21.5% decrease in soleus and gastrocnemius muscle weight
to bodyweight ratio in WT mice, respectively, indicating the HLS protocol induced
atrophy. Exercising prior to HLS resulted in a 5.6% and 8.1% decrease in soleus and
gastrocnemius weight to bodyweight ratio, respectively.
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Exercise increased mitochondrial associated markers (PGC-1α, TFAM, CS, SOD2), Slow myosin heavy chain (SMHC) expression, and reduced fiber-type transitioning
(Myh4). Observationally, Ex+HLS reveals decreased ROS expression compared to HLS.
Our data indicates the time prior to an atrophic setting, particularly caused by muscle
unloading, may be a useful period to intervene progressive exercise training to prevent
skeletal muscle atrophy and is associated with mitochondrial function and redox balance.

Based on the results of Chapter II, we created a third hypothesis that was two-fold
in which we state TFAM overexpression will prevent skeletal muscle atrophy and
combining TFAM overexpression with exercise will act synergistically to prevent
atrophy during HLS. To test this, we had to first obtain a viable C57Bl/6J-based
transgenic mouse model that positively overexpressed the TFAM gene and subject these
mice with the same HLS and exercise protocols as the wild-type mice in Chapter II. As
we see in Chapter III, all transgenic mice were first genotyped to confirm a positive
overexpression. Overexpressing TFAM results in a decrease of 8.3% in soleus and 2.6%
in gastrocnemius muscle weight to bodyweight ratio after only HLS compared to wildtype mice incurring a loss of 27.1% in soleus and 21.5% in gastrocnemius muscle after
HLS. Our data indicates TFAM may play a critical role in protecting skeletal muscle
from disuse atrophy and is correlated with increased expression of antioxidants (SOD-2)
and potential redox balance. Moreover, combining exercise with TFAM overexpression
had no synergistic effect compared to wild-type Ex+HLS. TFAM may be an attractive
molecule of interest for potential, future therapeutic development.
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Combining the results from these studies, the data supports the hypotheses that
exercise training prior to a disuse-induced atrophy scenario prevents skeletal muscle
atrophy and this is associated with reductions in markers of mitochondrial biogenesis and
function. Additionally, TFAM overexpression further results in the prevention of disuseinduced atrophy while combining exercise with TFAM overexpression appeared to have
no additional benefit. A mitochondrial mechanism increased by exercise that includes the
TFAM molecule appears to be an important factor in the prevention of skeletal muscle
atrophy and in the soleus and gastrocnemius. Refer to Figure 1 for a summary outline.

Exercise and TFAM Protect Skeletal Muscle
The goal of skeletal muscle atrophy research is ultimately prevention. Preventing
pathological tissue loss may sustain functional and metabolic activity of the muscle. The
patient prescribed bedrest after an orthopedic surgery, or any other atrophy scenario, has
not only a quality of life interest to preserve muscle, but also a financial interest to reduce
pharmaceutical and rehabilitation costs. The need to study interventions to prevent
disuse-induced muscle atrophy and the molecular mechanisms associated is warranted to
create treatments that improve the human condition.
The molecular processes resulting in atrophy can be viewed more simply as the
balance of protein degradation and cell apoptosis with protein synthesis. When
degradation and apoptosis exceed synthesis, a net protein loss occurs and the muscle
atrophies over time. Any treatment developed to prevent this condition must, in some
combination, reduce excessive degradation and apoptosis while increasing or maintaining
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levels of protein synthesis. The main goal of the project was to prevent this imbalance
with exercise and observe mitochondria variables associated with this prevention as a
possible mechanism.
The most prominent findings of this project are: (1) a short-term, concurrent
exercise training protocol prior to skeletal muscle unloading and disuse diminishes
skeletal muscle atrophy, (2) atrophy is associated with diminished mitochondrial markers
of biogenesis and function while exercising prior to disuse is associated with an increase
in these markers, and (3) the overexpression of the TFAM mitochondrial marker
diminishes atrophy associated with disuse. Our finding that exercise preconditioning
diminishes disuse atrophy could lead to changes in instructions to patients prior to
atrophy-inducing scenarios. In the case of the patient prescribed bedrest post-surgery, the
overseeing physician may consider prescribing an exercise protocol pre-surgery, if the
patient status allows, to attempt to prevent the negative consequences of bedrest on
skeletal muscle. Similarly, an astronaut going into a microgravity environment for a
shorter period of time could be prescribed exercise training pre-space travel to prevent
the unloading-induced atrophy typically observed in space flight (150). The findings that
this prevention is associated with increased mitochondrial markers, and particularly the
TFAM molecule, is a new area of introspection in skeletal muscle atrophy research. This
evidence could lead to molecularly directed pharmaceuticals in the future that attempt to
manipulate the mitochondria and TFAM to sustain mitochondrial biogenesis and function
pathways and protect mtDNA during muscle disuse and unloading. Further, the finding
that TFAM overexpression is also potentially linked to increased antioxidant expression
has not been fully elucidated in the literature and presents new opportunities of research.
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A more detailed explanation of these findings with the associated results from Chapter II
and Chapter III is discussed in the following sections.

Exercise preconditioning diminishes skeletal muscle atrophy. A principle finding of this
project was the reduction of disuse-induce atrophy using an exercise training treatment
prior to HLS. Our initial physiologic measurement of each group used Doppler laser
technology to assess blood flow of the lower hindlimb. Changes in blood flow to any
tissue may influence tissue health due to potential decrements in oxygen and nutrient
delivery as well as in waste removal. The research in this area is mixed. However, in a
more specific review of the microvasculature of disuse-induced skeletal muscle atrophy,
the authors note multiple animal studies reveal no differences in blood flow, mean blood
pressure, or vascular resistance in atrophied muscle (145). Similarly, we observed no
significant differences across all groups in blood flow, indicating initially that atrophy
was not flow-limited. This measurement is a function of RBCs and velocity and was
observed in a prominent vessel superior to the gastrocnemius in the hindlimb. While there
were no measurable differences in this vessel, microvasculature measurements may have
provided useful data in assessing the present results, as we did not account for
capillarization.
Prior research using HLS in mice reveal changes in muscle weight, CSA, and
fiber-type transitioning. Atrophy has been shown to occur in as little as 3 days (14), or
after 7 or more days of unloading and disuse (56, 66, 116). Here, we similarly observe
signs of atrophy occurring after 7 days of hindlimb suspension in both the soleus and
gastrocnemius of wild-type mice. These results indicated our atrophy protocol was viable
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and could be a target for treatment. Furthermore, while changes in nutrition status could
create variation between groups, bodyweights were recorded prior to and after HLS to
ensure no drastic reductions occurred while in HLS and food and water consumption was
monitored daily. In the current project, there were no significant differences in
bodyweight measurements in this regard. This finding was similar to Ferreira et al. in
which food intake and bodyweight were both recorded with no significant difference after
14 days of HLS (36).
Interventions in the literature to prevent atrophy include electrical stimulation,
nutrition, and exercise intra- or post-HLS (1, 46, 56, 104, 136). Interventions prior to the
atrophic setting to improve the atrophic condition are scarce. In Chapter II, we show
exercise training intervened prior to HLS prevented the loss of muscle weight and size.
Similarly, a 2016 study using a 4-month swimming protocol prior to immobilizing the
hindlimb of rats for 5 days in orthosis, which induces atrophy, revealed greater soleus
muscle weight and size compared to the non-exercise group. Although these treatments
constructs are very different, the theme of exercise preconditioning prior to disuse was
similar.
Fujino et al. measured soleus muscle mass after rats completed 1 session of
endurance exercise prior to HLS. While the exercise group trended greater in these
parameters, no significant differences were determined (37). This group also noted
reductions in MHC I after HLS with the exercise group trending higher but not
significantly. However, many of these results may be due to the use of a single exercise
session. A single session may not stress the musculature adequately to induce the
adaptive changes that provide significant protection of muscle in an HLS protocol.
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Furthermore, a single session removes the factor of progressive exercise training.
Adapting to exercise requires time and can be repetitiously surmounted to achieve,
incrementally, even greater adaptations. This method is the foundation of progressive
exercise training (142). Progressive training over time results in these incremental
increases and greater adaptations and possibly lead to greater skeletal muscle protection.
However, the translatable nature of a single session may be more useful for human
adherence. Therefore, we used a concurrent protocol in this study combining moderate
and more intense exercise over a shorter period (18 days) while still allowing enough
time for adaptations to surmount. We similarly observed nonsignificant soleus decreases
after HLS but also report significant decreases of SMHC in the gastrocnemius, revealing
potential muscle group differences in atrophy susceptibility. This could be due to the
differences in fiber-type makeup of each muscle and the associated characteristics of each
fiber type that may make some muscle fibers more prone to atrophy.
When a muscle is disused, it not only atrophies but the fiber-type makeup will
also remodel and transition from a slow fiber-type to a fast fiber-type (154). Through the
measurement of a fast-twitch fiber transitioning marker (Myh4) in the soleus, we found
when the hindlimbs were exposed to suspension, drastic increases in Myh4 were
observed indicating a decline in muscle quality occurred. When an exercise treatment
was intervened prior to suspension, this decline in quality was comparatively reduced,
indicating improved muscle quality. This is an important measurement to assess muscle
quality as a function of oxidative ability and resistance to fatigue. The same muscle group
with increased levels of fast-twitch fiber mRNA tend to be less resistant to fatigue to
those with lower levels of this transitioning marker, and vice versa. Part of the decline in
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muscle function observed in patients with significant atrophy may be due to this
decreased resistance to fatigue caused by a remodeled muscle.

Mitochondrial markers are associated with exercise protection. After establishing the
HLS protocol induces atrophy and an exercise intervention prior to HLS prevented
atrophy, a molecular analysis of mitochondrial markers was completed. Exercise was
chosen as a preconditioning treatment to prevent disuse-associated atrophy because of the
well-known inducing effect it has on mitochondrial biogenesis, particularly PGC-1 α and
TFAM, and mitochondrial function (61, 87, 119). Our analysis similarly led to the
important establishment that exercise increased markers of mitochondrial biogenesis and
function as well as antioxidant expression variably across both muscles.
In prior research, Liu et al. observed decreased mitochondrial respiration prior to
the activation of protein degradation pathways in a toxin-induced mouse atrophy model
(86). Another study observed markers of mitochondrial biogenesis increasing prior to the
regeneration of muscle after an initial atrophying scenario (28). Therefore, atrophy and
regeneration seemed to be preceded by changes in mitochondrial function and thus,
establishing mitochondrial importance with this tissue. In Chapter II, we show decreases
in markers of the mitochondria after HLS. Decreased mitochondrial biogenesis and
function markers suggests reductions in overall mitochondrial health. More specifically, a
reduction in TFAM is highly correlated with reduced mtDNA copy number and
decreased mitochondrial function (31). Our analysis reveal significant reductions of
TFAM in the gastrocnemius and trending decrease in the soleus. Based on this evidence
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and the literature data, the assumption made in this project is mtDNA copy number and
function are also diminished by the HLS protocol. This could be associated with the
reduction of ATP synthesis leading to reduced protein synthesis pathways, and redox
imbalance leading to the accumulation of ROS and the induction of apoptotic and
degradation pathways causing an imbalance in the skeletal muscle and a net protein loss
over the HLS protocol. Notably, most of these markers increased after exercise training
potentially providing an increased mitochondrial adaptation prior to entering HLS that
could sustain muscle health over the 7-day atrophying period according to the above
mechanisms.
When we examined redox imbalance, we observed increased superoxide anion
after HLS in both muscles and found SOD-2 expression generally decreased after HLS.
Similar superoxide anion results were observed by Cannavino et al. after a 7-day HLS
protocol in mice (14). Here, exercise training increased SOD-2 and links exercise leading
to greater redox balance. This balance could reduce excessive ROS accumulation that is
implicated in degradation aspects of skeletal muscle atrophy and may be due to the
combined factors of increased antioxidant expression and overall greater mitochondrial
health with exercise training. The combination of increased mitochondrial markers and
greater redox balance provides the framework for the associated molecular mechanisms
of exercise protecting skeletal muscle from atrophying during disuse.

TFAM overexpression diminishes skeletal muscle atrophy. Another major finding of this
project is the prevention of skeletal muscle atrophy via TFAM overexpression in a
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transgenic mouse model. This finding is particularly important, as it is the first time, to
our knowledge, a TFAM overexpression model has been used in the analysis of disuseinduce skeletal muscle atrophy. We hypothesized this finding based on the evidence in
the literature that indicated a possible role for TFAM in atrophy.
Initially, we see results from Kang et al. displaying the idea of a protective effect
of PGC-1α overexpression on mice skeletal muscle during limb immobilization (66).
Cannavino et al. similarly show overexpressing PGC-1α in transgenic mice diminished
skeletal muscle atrophy during hindlimb unloading (14). PGC-1α coactivating with NRF1 and NRF-2 initiates the transcription of TFAM from nuclear DNA. Although PGC-1α
is a diverse protein with many powerful interactions, its role in mitochondrial health
includes the transcription of the TFAM molecule and is worth isolating in research for
further study.
TFAM overexpression research is scarce in pathological scenarios. A 2005 study
reported the use of a TFAM transgenic mouse model in a myocardial infarction study and
results indicate TFAM overexpression ameliorated left ventricular remodeling, providing
a cardiomyocyte protective effect (52). Other in vitro studies similarly reveal a
cardiomyocyte protective role via TFAM overexpression (38, 51). Reviewing the
protective effects in cardiac muscle also provides evidence for a potential use in skeletal
muscle, even though there are differences between the tissues. From a redox balance
standpoint, mitochondrial dysfunction is highly correlated with excessive ROS and is a
variable that should be considered when attempting to improve muscle health. As
previous research has already shown, TFAM protects mtDNA from degradation via ROS
binding while also increasing mtDNA transcription, mtDNA copy number, and
136

mitochondrial biogenesis. This data provides evidence that the overexpression of this
molecule can prevent atrophy, as atrophy is correlated to diminished mitochondrial
factors. In Chapter II we found decreases in TFAM after the HLS protocol. Based on this
finding, in Chapter III we tested TFAM overexpression in HLS which led to greater
skeletal muscle weight to bodyweight ratios and CSA of muscle fibers and echoed our
hypothesis that TFAM would improve this condition. Increased TFAM transcripts may
have led to increased TFAM protein translation and import into the mitochondria.
Assumingly, this protein could interact with mtDNA and protect it from the excessive
ROS that accrues during HLS and increase or sustain mitochondrial biogenesis and
function by activating transcription of mtDNA and retaining mitochondrial function with
subsequent ATP synthesis and redox balance. As discussed previously, these aspects of
are of key importance in protein degradation, apoptosis, and protein synthesis in skeletal
muscle.
Kang’s group, in the analysis of skeletal muscle using a PGC-1α overexpression
mouse transgenic model after limb immobilization-remobilization, note decreased
superoxide and increased SOD-2 expression in the transgenic mouse model (66). This
positive correlation between PGC-1α and antioxidants has also been shown previously in
skeletal muscle (67). In Chapter II, we observe increased antioxidant status across both
muscles in all TFAM transgenic groups, including controls. This observation is important
because the above research on PGC-1α link the increase in antioxidants to mechanisms
preceding or outside of TFAM. Here we are linking increased antioxidants specifically to
TFAM overexpression while data in the literature on this connection is scarce. However,
a 2009 study isolating mtDNA nucleoids revealed the presence of SOD-2 within each
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nucleoid, potentially acting as a front-line antioxidant defense barrier for mtDNA (72).
Speculatively, it could be overexpressing TFAM results in increased mtDNA-TFAM
protein interaction and greater nucleoid formation, leading to greater SOD-2 expression
within these nucleoids. A specific mechanism here, however, appears to be unknown and
worth investigation. Through increased TFAM overexpression and increased antioxidant
expression, the typical inducer of protein degradation and mitochondrial based apoptotic
pathways (i.e. ROS) could be neutralized during muscle disuse. Many of the major
molecular degradation factors leading to muscle atrophy are therefore prevented or
diminished and could account for the positive effects of TFAM overexpression
preventing skeletal muscle atrophy. Indeed, here we observed diminished ROS
accumulation in the form of superoxide anion across all TFAM groups as observational
evidence of this potential mechanism.
Another point of emphasis in this project was to compare the results of two
separate muscles with very different fiber-type makeups in the soleus and gastrocnemius.
While both muscles appeared to atrophy in wild-type mice after HLS, TFAM
overexpression mice were both significantly greater than wild-type HLS. The
gastrocnemius responded, potentially, to a greater extent to TFAM overexpression
compared to the soleus. TFAM HLS gastrocnemius muscle weight to body weight ratio
was nearly identical to TFAM Control, with CSA and immunofluorescence imaging of
the muscle fibers revealing similar results. In Chapter II, we show a significant decrease
in TFAM in the gastrocnemius and not in the soleus after HLS. These results combined
with the more robust response of the gastrocnemius to TFAM overexpression may
indicate the gastrocnemius is more susceptible to mitochondrial changes and thus, a
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better responder to TFAM overexpression. We also observed greater TFAM mRNA
levels in the gastrocnemius compared to the soleus in transgenic groups. The
gastrocnemius, with a greater fast-twitch fiber makeup, may also be more receptive to the
random integration of the TFAM transgenic construct. In the Cannavino et al. study, the
authors note the potential for certain promoters to be more highly expressed in fast-fibers
compared to slow-fibers (14). Speculatively, this may account for expression differences
between muscle types.
A final finding of this project is that combining exercise training with TFAM
overexpression resulted in no synergistic effects in diminishing skeletal muscle atrophy.
One could assume, due to the diverse signaling response to exercise, adding an exercise
treatment to TFAM overexpression would further prevent muscle atrophy. Here, in most
measures, TFAM Ex+HLS was not significantly different when compared to wild-type
Ex+HLS, which countered our proposed hypothesis. This could be due to possible
physiological limitations in available mRNA and messaging pathways leading to
mitochondrial protection. With the TFAM gene already being overexpressed in
transgenic mice, adding in mitochondrial biogenesis signals in the form of exercise may
not have been able to further affect this process. Due to these observations we conclude
this combination of treatments was not superior to either treatment alone.

Future Directions
We have demonstrated through the results of this project that exercise training
prior to muscle unloading clearly attenuates disuse-induced skeletal muscle atrophy and
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is associated with changes in particular mitochondrial markers, most notably TFAM,
which can be manipulated to also play a protective role. However, the acquisition of new
knowledge brings forth the attainment of new questions, which we find to be the same
here. For example, what changes occur to the markers of degradation and synthesis
during HLS? Two prominent degradation molecules and E3 ubiquitin ligases, muscle
RING finger-1 (Murf-1) and muscle atrophy F-Box (MAFbx)/Atrogin-1, have been
shown to be transcriptionally increased during skeletal muscle atrophy in over 10 years of
research (11). While multiple studies mentioned previously have linked mitochondrial
dysfunction and ROS to these degradation markers, future research into a comprehensive
connection of degradation and apoptotic markers to the treatments in this project and
atrophy prevention is warranted. Did exercise prior to HLS reduce degradation
molecules? Did TFAM overexpression reduce pathways to cell apoptosis? These
questions could build upon our molecular understanding of the current research.
While previously mentioned research linked decreases in protein synthesis
pathways to mitochondrial dysfunction and ROS, direct measurement of these pathways
was not conducted in the present study. A useful study design could be the analysis of the
Akt/mTOR pathway in conjunction with TFAM overexpression and exercise treatments.
Particularly in exercise, a known inducer of mTOR (71), a protein synthesis analysis
study could provide useful data. Furthermore, different types of exercise could be studied
to observe any superiority in training styles. For example, while resistance training
appears to activate protein synthesis greater than other forms of exercise, will this type of
exercise alone or in conjunction with other forms or exercise provide superior results due
to increased synthesis levels going in to HLS?
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Another potential area to explore based off the current data derived from this
project is a deeper mitochondrial analysis. While many of the markers measured here
have been thoroughly linked to mitochondrial dysfunction, a specific functional study
analyzing mtDNA, respiration markers, O2 consumption and ATP synthesis rates, and
possibly transmission electron microscopy to visualize mitochondrial size and number
would be useful to explore. Similarly, while our ROS measurements matched previous
research in HLS, an in-depth analysis of ROS using multiple measurement techniques
during skeletal muscle atrophy and the associated mitochondrial effects could also be
another useful endeavor to elucidate ROS in atrophy.
Due to the results of TFAM overexpression, pharmaceutical and therapeutic
options that are TFAM-directed may be useful to study. If TFAM transcription can be
pharmacologically stimulated or if the role of TFAM can be pharmacologically
replicated, a medicinal intervention could be synthesized. Provided greater basic research
is needed, the use of a medicinal intervention to protect mtDNA and potentially
mitochondrial function during scenarios of skeletal muscle disuse could reduce healthcare
costs and improve the quality of lives of numerous patients every year. Translationally, a
project using human subjects choosing elective surgery that will be prescribed bedrest
post-surgery could be directed into an exercise protocol prior to going into surgery. This
could translate the results of our basic research and is an obvious next step that we
believe should be undertaken.
Collectively, the results of this project provide useful data into the prevention of
disuse-induced skeletal muscle atrophy. Through the highlighting of exercise and TFAM,
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it is my sincerest hope this information will be used to build upon viable treatment
options of the future.
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Chapter 1 is a published review article while Chapter 2 and Chapter 3 are under
review for publication as original research manuscripts. Proper copyright materials have
been obtained for all published material contained within this dissertation and are
referenced within this document.
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